Gene Symbol | Gene ID | Gene Info |
---|---|---|
BPTF
|
ENSG00000171634.12 | bromodomain PHD finger transcription factor |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr17_65856959_65857110 | BPTF | 14002 | 0.169696 | 0.92 | 3.8e-04 | Click! |
chr17_65825111_65825409 | BPTF | 3002 | 0.227758 | 0.88 | 1.8e-03 | Click! |
chr17_65861788_65861939 | BPTF | 9173 | 0.182769 | 0.86 | 3.1e-03 | Click! |
chr17_65823632_65824050 | BPTF | 1583 | 0.353561 | 0.80 | 1.0e-02 | Click! |
chr17_65924719_65924870 | BPTF | 8578 | 0.176299 | -0.72 | 2.9e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chrX_20229682_20229905 | 3.39 |
RPS6KA3 |
ribosomal protein S6 kinase, 90kDa, polypeptide 3 |
7186 |
0.22 |
chr3_48521637_48521803 | 2.54 |
SHISA5 |
shisa family member 5 |
7103 |
0.1 |
chr20_2722949_2723333 | 2.52 |
EBF4 |
early B-cell factor 4 |
36254 |
0.09 |
chr8_126941263_126941691 | 2.44 |
ENSG00000206695 |
. |
28282 |
0.26 |
chr11_128601305_128601624 | 2.42 |
FLI1 |
Fli-1 proto-oncogene, ETS transcription factor |
33221 |
0.15 |
chr5_110568093_110568590 | 2.42 |
CAMK4 |
calcium/calmodulin-dependent protein kinase IV |
8557 |
0.23 |
chr11_118746463_118746614 | 2.36 |
CXCR5 |
chemokine (C-X-C motif) receptor 5 |
7937 |
0.1 |
chr12_104296008_104296159 | 2.32 |
HSP90B1 |
heat shock protein 90kDa beta (Grp94), member 1 |
27802 |
0.12 |
chr3_67055299_67055450 | 2.27 |
KBTBD8 |
kelch repeat and BTB (POZ) domain containing 8 |
6025 |
0.35 |
chr11_128551207_128551388 | 2.25 |
RP11-744N12.3 |
|
5026 |
0.2 |
chr17_26206098_26206388 | 2.25 |
LYRM9 |
LYR motif containing 9 |
4080 |
0.19 |
chr6_157790793_157790944 | 2.25 |
ZDHHC14 |
zinc finger, DHHC-type containing 14 |
11297 |
0.24 |
chr8_81289205_81289813 | 2.24 |
ENSG00000252884 |
. |
28242 |
0.19 |
chr18_60883221_60883629 | 2.22 |
ENSG00000238988 |
. |
21527 |
0.2 |
chr3_111854444_111854779 | 2.21 |
RP11-757F18.5 |
|
2341 |
0.24 |
chr17_37968472_37968629 | 2.20 |
IKZF3 |
IKAROS family zinc finger 3 (Aiolos) |
34072 |
0.11 |
chr3_150917630_150918104 | 2.16 |
GPR171 |
G protein-coupled receptor 171 |
3112 |
0.2 |
chr9_37301598_37301921 | 2.16 |
ENSG00000216070 |
. |
5658 |
0.23 |
chr20_39773341_39773711 | 2.16 |
RP1-1J6.2 |
|
6883 |
0.21 |
chr13_45973094_45973360 | 2.15 |
SLC25A30 |
solute carrier family 25, member 30 |
19282 |
0.14 |
chr4_90207457_90208038 | 2.11 |
GPRIN3 |
GPRIN family member 3 |
21414 |
0.27 |
chr8_80966900_80967051 | 2.10 |
MRPS28 |
mitochondrial ribosomal protein S28 |
24451 |
0.18 |
chr14_31679082_31679233 | 2.10 |
HECTD1 |
HECT domain containing E3 ubiquitin protein ligase 1 |
2147 |
0.28 |
chr3_33094206_33094581 | 2.09 |
GLB1 |
galactosidase, beta 1 |
43891 |
0.12 |
chr2_84761390_84761724 | 2.08 |
DNAH6 |
dynein, axonemal, heavy chain 6 |
16614 |
0.27 |
chr17_48219025_48219176 | 2.04 |
AC002401.1 |
|
6149 |
0.1 |
chr8_37134401_37134693 | 2.01 |
RP11-150O12.6 |
|
239992 |
0.02 |
chr6_128236322_128236473 | 2.01 |
THEMIS |
thymocyte selection associated |
3288 |
0.36 |
chr8_101388311_101388462 | 1.97 |
ENSG00000265599 |
. |
6605 |
0.23 |
chr12_92439916_92440083 | 1.94 |
C12orf79 |
chromosome 12 open reading frame 79 |
90798 |
0.08 |
chr12_48218547_48218835 | 1.93 |
HDAC7 |
histone deacetylase 7 |
4296 |
0.19 |
chr4_122112223_122112496 | 1.93 |
ENSG00000252183 |
. |
1699 |
0.43 |
chr8_126947838_126948180 | 1.92 |
ENSG00000206695 |
. |
34814 |
0.24 |
chr10_8107515_8108115 | 1.92 |
GATA3 |
GATA binding protein 3 |
11046 |
0.31 |
chr12_111173855_111174006 | 1.92 |
PPP1CC |
protein phosphatase 1, catalytic subunit, gamma isozyme |
3142 |
0.26 |
chr15_64882132_64882366 | 1.91 |
ENSG00000207223 |
. |
62838 |
0.08 |
chr2_145281196_145281632 | 1.90 |
ZEB2 |
zinc finger E-box binding homeobox 2 |
2793 |
0.31 |
chr7_100278888_100279039 | 1.88 |
GNB2 |
guanine nucleotide binding protein (G protein), beta polypeptide 2 |
5202 |
0.1 |
chr19_10214843_10215021 | 1.86 |
ANGPTL6 |
angiopoietin-like 6 |
1460 |
0.16 |
chr10_87372001_87372388 | 1.85 |
RP11-93H12.2 |
|
7044 |
0.23 |
chr10_116284270_116284566 | 1.84 |
ABLIM1 |
actin binding LIM protein 1 |
2176 |
0.42 |
chr2_95729055_95729206 | 1.83 |
AC103563.9 |
|
10209 |
0.17 |
chr6_154478833_154479416 | 1.83 |
OPRM1 |
opioid receptor, mu 1 |
71482 |
0.12 |
chr7_50462451_50462702 | 1.83 |
ENSG00000200815 |
. |
40502 |
0.17 |
chr18_77282001_77282189 | 1.82 |
AC018445.1 |
Uncharacterized protein |
6038 |
0.3 |
chr8_61779004_61779374 | 1.82 |
RP11-33I11.2 |
|
57024 |
0.16 |
chr17_6937501_6937652 | 1.81 |
SLC16A13 |
solute carrier family 16, member 13 |
1818 |
0.14 |
chr1_203732630_203732922 | 1.81 |
LAX1 |
lymphocyte transmembrane adaptor 1 |
1528 |
0.35 |
chr17_37956193_37956565 | 1.81 |
IKZF3 |
IKAROS family zinc finger 3 (Aiolos) |
21901 |
0.13 |
chr1_198617249_198617743 | 1.80 |
PTPRC |
protein tyrosine phosphatase, receptor type, C |
9204 |
0.24 |
chr5_156605884_156606035 | 1.80 |
ITK |
IL2-inducible T-cell kinase |
1878 |
0.25 |
chr4_110488477_110488628 | 1.79 |
CCDC109B |
coiled-coil domain containing 109B |
6406 |
0.25 |
chr17_49504776_49504995 | 1.78 |
UTP18 |
UTP18 small subunit (SSU) processome component homolog (yeast) |
142256 |
0.04 |
chr5_58448519_58448803 | 1.78 |
RP11-266N13.2 |
|
113073 |
0.07 |
chr14_61858196_61858389 | 1.77 |
PRKCH |
protein kinase C, eta |
880 |
0.68 |
chr13_41190432_41190589 | 1.77 |
FOXO1 |
forkhead box O1 |
50224 |
0.14 |
chr1_154322015_154322166 | 1.76 |
ENSG00000238365 |
. |
10871 |
0.1 |
chr5_67552449_67552681 | 1.76 |
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
16839 |
0.26 |
chr20_3795874_3796116 | 1.76 |
AP5S1 |
adaptor-related protein complex 5, sigma 1 subunit |
5183 |
0.13 |
chr14_99721598_99721757 | 1.75 |
AL109767.1 |
|
7608 |
0.22 |
chr17_46494618_46494841 | 1.74 |
SKAP1 |
src kinase associated phosphoprotein 1 |
12823 |
0.14 |
chr20_1653030_1653704 | 1.74 |
ENSG00000242348 |
. |
6361 |
0.17 |
chr1_159016145_159016303 | 1.73 |
ENSG00000265589 |
. |
12815 |
0.17 |
chr1_65342372_65342702 | 1.73 |
JAK1 |
Janus kinase 1 |
89650 |
0.08 |
chr14_99717010_99717326 | 1.73 |
AL109767.1 |
|
12117 |
0.21 |
chr13_108959121_108959526 | 1.72 |
ENSG00000223177 |
. |
5644 |
0.26 |
chr9_37036111_37036351 | 1.72 |
PAX5 |
paired box 5 |
2128 |
0.34 |
chr1_183857146_183857438 | 1.71 |
COLGALT2 |
collagen beta(1-O)galactosyltransferase 2 |
58460 |
0.13 |
chr19_2112668_2112819 | 1.71 |
AP3D1 |
adaptor-related protein complex 3, delta 1 subunit |
1862 |
0.22 |
chr15_26056534_26056770 | 1.70 |
ENSG00000199214 |
. |
6478 |
0.21 |
chr5_145585619_145585871 | 1.70 |
RBM27 |
RNA binding motif protein 27 |
2582 |
0.28 |
chr2_143893827_143894054 | 1.69 |
ARHGAP15 |
Rho GTPase activating protein 15 |
7057 |
0.27 |
chr22_40444541_40444692 | 1.69 |
TNRC6B |
trinucleotide repeat containing 6B |
3138 |
0.23 |
chr2_27615027_27615178 | 1.69 |
ZNF513 |
zinc finger protein 513 |
11445 |
0.08 |
chr5_14559897_14560191 | 1.68 |
FAM105A |
family with sequence similarity 105, member A |
21840 |
0.23 |
chr19_34759219_34759485 | 1.67 |
KIAA0355 |
KIAA0355 |
13850 |
0.21 |
chr6_135339081_135339241 | 1.67 |
HBS1L |
HBS1-like (S. cerevisiae) |
9133 |
0.22 |
chr3_105469425_105469649 | 1.67 |
CBLB |
Cbl proto-oncogene B, E3 ubiquitin protein ligase |
48492 |
0.2 |
chr5_75766935_75767521 | 1.67 |
IQGAP2 |
IQ motif containing GTPase activating protein 2 |
66979 |
0.12 |
chr2_99341231_99341382 | 1.67 |
MGAT4A |
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A |
1853 |
0.41 |
chr1_101587391_101587816 | 1.66 |
ENSG00000252765 |
. |
11106 |
0.2 |
chr2_204810952_204811163 | 1.65 |
ICOS |
inducible T-cell co-stimulator |
9554 |
0.28 |
chr9_129159741_129160418 | 1.65 |
ENSG00000253079 |
. |
10610 |
0.2 |
chr20_46134281_46134451 | 1.65 |
NCOA3 |
nuclear receptor coactivator 3 |
3681 |
0.21 |
chr14_97875302_97875453 | 1.65 |
ENSG00000240730 |
. |
121133 |
0.07 |
chr11_60869213_60869364 | 1.64 |
CD5 |
CD5 molecule |
579 |
0.75 |
chr1_167472608_167472887 | 1.64 |
CD247 |
CD247 molecule |
15028 |
0.19 |
chr16_68165442_68165593 | 1.64 |
NFATC3 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 |
8584 |
0.12 |
chr1_15906092_15906492 | 1.64 |
AGMAT |
agmatine ureohydrolase (agmatinase) |
5313 |
0.12 |
chr7_76984643_76984884 | 1.64 |
GSAP |
gamma-secretase activating protein |
25079 |
0.21 |
chr14_50411900_50412331 | 1.64 |
ENSG00000251929 |
. |
43447 |
0.1 |
chr10_17469095_17469250 | 1.62 |
ST8SIA6-AS1 |
ST8SIA6 antisense RNA 1 |
19146 |
0.17 |
chr11_44701415_44701797 | 1.62 |
TSPAN18 |
tetraspanin 18 |
46409 |
0.15 |
chr6_112311435_112311966 | 1.62 |
WISP3 |
WNT1 inducible signaling pathway protein 3 |
63575 |
0.11 |
chr17_40467183_40467619 | 1.62 |
STAT5A |
signal transducer and activator of transcription 5A |
9213 |
0.13 |
chr22_17570739_17570890 | 1.62 |
IL17RA |
interleukin 17 receptor A |
4965 |
0.18 |
chr17_64403758_64403909 | 1.61 |
RP11-4F22.2 |
|
7258 |
0.25 |
chrX_153086920_153087071 | 1.61 |
PDZD4 |
PDZ domain containing 4 |
8356 |
0.1 |
chr11_3991307_3991580 | 1.61 |
STIM1 |
stromal interaction molecule 1 |
22870 |
0.17 |
chr4_37818298_37818707 | 1.61 |
PGM2 |
phosphoglucomutase 2 |
9753 |
0.26 |
chr16_68325697_68326048 | 1.60 |
ENSG00000252026 |
. |
7651 |
0.08 |
chr1_54381840_54381991 | 1.60 |
DIO1 |
deiodinase, iodothyronine, type I |
22031 |
0.12 |
chr2_12641093_12641393 | 1.59 |
ENSG00000207183 |
. |
89616 |
0.1 |
chr11_117919369_117919529 | 1.59 |
ENSG00000272075 |
. |
18503 |
0.15 |
chr16_11879926_11880367 | 1.59 |
ZC3H7A |
zinc finger CCCH-type containing 7A |
3256 |
0.2 |
chr17_4075964_4076115 | 1.59 |
RP11-810M2.2 |
|
8835 |
0.12 |
chr5_35833854_35834095 | 1.59 |
CTD-2113L7.1 |
|
6854 |
0.21 |
chr19_48827788_48827939 | 1.58 |
EMP3 |
epithelial membrane protein 3 |
719 |
0.53 |
chr2_68947558_68947872 | 1.58 |
ARHGAP25 |
Rho GTPase activating protein 25 |
10081 |
0.25 |
chr5_39208813_39209149 | 1.58 |
FYB |
FYN binding protein |
5852 |
0.3 |
chr13_41152924_41153075 | 1.57 |
AL133318.1 |
Uncharacterized protein |
41676 |
0.18 |
chr15_60850795_60851057 | 1.57 |
CTD-2501E16.2 |
|
28754 |
0.16 |
chr9_37035960_37036111 | 1.56 |
PAX5 |
paired box 5 |
1932 |
0.36 |
chr17_42323284_42323440 | 1.56 |
AC003102.1 |
|
3874 |
0.1 |
chr9_123658587_123658744 | 1.55 |
TRAF1 |
TNF receptor-associated factor 1 |
18185 |
0.17 |
chr14_61846188_61846410 | 1.55 |
PRKCH |
protein kinase C, eta |
11113 |
0.24 |
chr21_16886090_16886335 | 1.54 |
ENSG00000212564 |
. |
100390 |
0.08 |
chr6_132230969_132231170 | 1.54 |
RP11-69I8.3 |
|
41017 |
0.14 |
chr11_60750434_60750585 | 1.54 |
ENSG00000207153 |
. |
2130 |
0.21 |
chr13_99728392_99728911 | 1.54 |
DOCK9 |
dedicator of cytokinesis 9 |
10009 |
0.2 |
chr17_14100467_14100762 | 1.54 |
AC005224.2 |
|
13191 |
0.2 |
chr2_97025219_97025397 | 1.53 |
NCAPH |
non-SMC condensin I complex, subunit H |
4910 |
0.19 |
chr22_40730411_40730669 | 1.53 |
ADSL |
adenylosuccinate lyase |
11967 |
0.19 |
chr6_24839852_24840003 | 1.53 |
ENSG00000263391 |
. |
366 |
0.86 |
chr16_74637720_74637954 | 1.53 |
GLG1 |
golgi glycoprotein 1 |
3155 |
0.29 |
chr4_109061052_109061203 | 1.52 |
LEF1 |
lymphoid enhancer-binding factor 1 |
26330 |
0.2 |
chr4_48133453_48133604 | 1.52 |
TXK |
TXK tyrosine kinase |
2745 |
0.23 |
chr17_56708836_56709039 | 1.52 |
ENSG00000212195 |
. |
260 |
0.88 |
chr6_158307079_158307351 | 1.52 |
RP3-403L10.3 |
|
6603 |
0.18 |
chr12_122821380_122821531 | 1.51 |
CLIP1 |
CAP-GLY domain containing linker protein 1 |
27109 |
0.18 |
chr9_4572075_4572543 | 1.51 |
SLC1A1 |
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 |
26 |
0.98 |
chr14_24640361_24640512 | 1.51 |
REC8 |
REC8 meiotic recombination protein |
626 |
0.41 |
chr15_91863032_91863276 | 1.51 |
SV2B |
synaptic vesicle glycoprotein 2B |
94054 |
0.09 |
chr15_66176692_66176843 | 1.51 |
RAB11A |
RAB11A, member RAS oncogene family |
14416 |
0.19 |
chr19_39029001_39029486 | 1.51 |
AC067969.2 |
|
1475 |
0.28 |
chr8_101474989_101475316 | 1.51 |
KB-1615E4.2 |
|
12751 |
0.19 |
chr1_29245263_29245530 | 1.50 |
EPB41 |
erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked) |
4305 |
0.22 |
chr10_70729517_70729937 | 1.50 |
ENSG00000266122 |
. |
3955 |
0.18 |
chr6_160434125_160434276 | 1.50 |
AIRN |
antisense of IGF2R non-protein coding RNA |
5504 |
0.25 |
chr5_175084319_175084482 | 1.50 |
HRH2 |
histamine receptor H2 |
633 |
0.75 |
chr13_103255109_103255433 | 1.49 |
TPP2 |
tripeptidyl peptidase II |
5898 |
0.21 |
chr10_4121743_4121894 | 1.49 |
KLF6 |
Kruppel-like factor 6 |
294345 |
0.01 |
chr4_40228763_40229105 | 1.49 |
RHOH |
ras homolog family member H |
26970 |
0.19 |
chr3_53009004_53009155 | 1.49 |
SFMBT1 |
Scm-like with four mbt domains 1 |
70202 |
0.07 |
chr21_43835879_43836201 | 1.49 |
ENSG00000252619 |
. |
1662 |
0.28 |
chr21_47788967_47789205 | 1.49 |
PCNT |
pericentrin |
45050 |
0.1 |
chr2_9919691_9919842 | 1.49 |
ENSG00000200034 |
. |
38854 |
0.16 |
chr10_63999987_64000138 | 1.48 |
RTKN2 |
rhotekin 2 |
4040 |
0.33 |
chr17_37935039_37935190 | 1.48 |
IKZF3 |
IKAROS family zinc finger 3 (Aiolos) |
636 |
0.65 |
chr2_106675152_106675303 | 1.48 |
C2orf40 |
chromosome 2 open reading frame 40 |
4523 |
0.31 |
chr1_39505386_39505552 | 1.48 |
NDUFS5 |
NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase) |
13479 |
0.17 |
chr13_114891947_114892268 | 1.46 |
RASA3 |
RAS p21 protein activator 3 |
5920 |
0.23 |
chr9_131418486_131418680 | 1.46 |
WDR34 |
WD repeat domain 34 |
377 |
0.78 |
chr1_101763741_101764115 | 1.46 |
RP4-575N6.5 |
|
55214 |
0.12 |
chr13_43067687_43067970 | 1.46 |
TNFSF11 |
tumor necrosis factor (ligand) superfamily, member 11 |
69044 |
0.14 |
chr2_173328951_173329156 | 1.45 |
AC078883.3 |
|
1687 |
0.35 |
chr9_4600257_4600746 | 1.45 |
SLC1A1 |
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 |
28166 |
0.18 |
chr7_38397041_38397330 | 1.45 |
AMPH |
amphiphysin |
105528 |
0.08 |
chr5_75786926_75787121 | 1.45 |
IQGAP2 |
IQ motif containing GTPase activating protein 2 |
56211 |
0.14 |
chr2_234933662_234934166 | 1.44 |
SPP2 |
secreted phosphoprotein 2, 24kDa |
25409 |
0.2 |
chr13_112041909_112042060 | 1.44 |
TEX29 |
testis expressed 29 |
68969 |
0.13 |
chr2_144413289_144413443 | 1.43 |
AC092652.1 |
|
382 |
0.88 |
chr4_103531018_103531169 | 1.43 |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
32072 |
0.18 |
chr17_71754301_71754605 | 1.43 |
SDK2 |
sidekick cell adhesion molecule 2 |
114225 |
0.06 |
chr3_98284443_98285102 | 1.43 |
CPOX |
coproporphyrinogen oxidase |
27795 |
0.13 |
chr6_74158126_74158277 | 1.43 |
MB21D1 |
Mab-21 domain containing 1 |
3781 |
0.11 |
chr5_169689485_169689978 | 1.42 |
LCP2 |
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
4569 |
0.25 |
chr20_44690293_44690444 | 1.42 |
NCOA5 |
nuclear receptor coactivator 5 |
28223 |
0.11 |
chr1_100876837_100877178 | 1.42 |
ENSG00000216067 |
. |
32676 |
0.16 |
chr18_60880123_60880495 | 1.42 |
ENSG00000238988 |
. |
18411 |
0.21 |
chr5_138188746_138188897 | 1.42 |
CTNNA1 |
catenin (cadherin-associated protein), alpha 1, 102kDa |
20906 |
0.18 |
chr11_13891185_13891445 | 1.42 |
ENSG00000201856 |
. |
37822 |
0.21 |
chr3_42597426_42598002 | 1.41 |
SEC22C |
SEC22 vesicle trafficking protein homolog C (S. cerevisiae) |
7410 |
0.14 |
chr12_917643_917888 | 1.41 |
ENSG00000221439 |
. |
27466 |
0.18 |
chr2_144012089_144012556 | 1.41 |
RP11-190J23.1 |
|
82581 |
0.1 |
chr2_202136814_202137163 | 1.41 |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
373 |
0.87 |
chr12_90055484_90055744 | 1.41 |
ATP2B1 |
ATPase, Ca++ transporting, plasma membrane 1 |
5726 |
0.23 |
chr5_109042881_109043032 | 1.41 |
ENSG00000202512 |
. |
7421 |
0.21 |
chr22_40731014_40731199 | 1.41 |
ADSL |
adenylosuccinate lyase |
11401 |
0.19 |
chr14_71454274_71454525 | 1.41 |
PCNX |
pecanex homolog (Drosophila) |
25349 |
0.26 |
chr1_67426609_67426760 | 1.41 |
MIER1 |
mesoderm induction early response 1, transcriptional regulator |
30758 |
0.16 |
chr5_66455749_66455900 | 1.41 |
MAST4 |
microtubule associated serine/threonine kinase family member 4 |
17562 |
0.24 |
chr22_40336110_40336397 | 1.41 |
GRAP2 |
GRB2-related adaptor protein 2 |
6568 |
0.18 |
chr22_31673029_31673483 | 1.41 |
PIK3IP1 |
phosphoinositide-3-kinase interacting protein 1 |
15125 |
0.1 |
chr1_160510513_160511051 | 1.40 |
RP11-528G1.2 |
|
3919 |
0.16 |
chr2_68946553_68946704 | 1.40 |
ARHGAP25 |
Rho GTPase activating protein 25 |
8994 |
0.26 |
chr1_17528561_17528716 | 1.40 |
PADI1 |
peptidyl arginine deiminase, type I |
2983 |
0.24 |
chr4_154038224_154038415 | 1.40 |
TRIM2 |
tripartite motif containing 2 |
35326 |
0.2 |
chr17_47828102_47828408 | 1.40 |
FAM117A |
family with sequence similarity 117, member A |
13238 |
0.15 |
chr1_144363452_144363904 | 1.40 |
PPIAL4B |
peptidylprolyl isomerase A (cyclophilin A)-like 4B |
568 |
0.78 |
chr6_119589457_119589633 | 1.40 |
ENSG00000200732 |
. |
58901 |
0.14 |
chr15_78738010_78738161 | 1.40 |
IREB2 |
iron-responsive element binding protein 2 |
7459 |
0.17 |
chr17_1775725_1776037 | 1.39 |
RPA1 |
replication protein A1, 70kDa |
6448 |
0.16 |
chr2_106454510_106454690 | 1.39 |
NCK2 |
NCK adaptor protein 2 |
13604 |
0.23 |
chr5_72154664_72154815 | 1.39 |
TNPO1 |
transportin 1 |
10728 |
0.19 |
chr4_149361761_149361912 | 1.39 |
NR3C2 |
nuclear receptor subfamily 3, group C, member 2 |
1540 |
0.56 |
chr17_38771222_38771726 | 1.39 |
SMARCE1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 |
17068 |
0.14 |
chr21_32727395_32727715 | 1.39 |
TIAM1 |
T-cell lymphoma invasion and metastasis 1 |
10961 |
0.3 |
chr1_198655968_198656151 | 1.39 |
RP11-553K8.5 |
|
19869 |
0.24 |
chr7_50455347_50455498 | 1.38 |
ENSG00000200815 |
. |
47656 |
0.15 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 8.0 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
1.8 | 5.4 | GO:0030223 | neutrophil differentiation(GO:0030223) |
1.8 | 7.1 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
1.6 | 1.6 | GO:0002326 | B cell lineage commitment(GO:0002326) |
1.6 | 4.8 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
1.5 | 6.0 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
1.4 | 9.9 | GO:0007172 | signal complex assembly(GO:0007172) |
1.4 | 4.2 | GO:0002911 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) positive regulation of T cell anergy(GO:0002669) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) positive regulation of lymphocyte anergy(GO:0002913) |
1.4 | 4.2 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
1.4 | 5.6 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
1.2 | 3.6 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
1.2 | 9.4 | GO:0006491 | N-glycan processing(GO:0006491) |
1.2 | 3.5 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.2 | 5.9 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.2 | 3.5 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
1.1 | 3.4 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
1.1 | 5.6 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
1.1 | 4.4 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
1.1 | 3.2 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
1.0 | 2.1 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
1.0 | 3.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
1.0 | 8.1 | GO:0002837 | regulation of response to tumor cell(GO:0002834) positive regulation of response to tumor cell(GO:0002836) regulation of immune response to tumor cell(GO:0002837) positive regulation of immune response to tumor cell(GO:0002839) |
1.0 | 2.0 | GO:0001821 | histamine secretion(GO:0001821) |
0.9 | 2.8 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.9 | 0.9 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.9 | 0.9 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.9 | 10.1 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.9 | 0.9 | GO:0051665 | membrane raft localization(GO:0051665) |
0.9 | 2.7 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.9 | 1.8 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.9 | 2.7 | GO:0010957 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.9 | 2.6 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.8 | 2.5 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.8 | 2.4 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.8 | 3.2 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.8 | 4.0 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.8 | 2.4 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.8 | 7.0 | GO:0043368 | positive T cell selection(GO:0043368) |
0.8 | 3.9 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.8 | 2.3 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.7 | 0.7 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.7 | 2.2 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.7 | 47.0 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.7 | 0.7 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
0.7 | 1.4 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.7 | 2.2 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.7 | 0.7 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.7 | 2.8 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.7 | 4.1 | GO:0051294 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.7 | 1.4 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.7 | 1.4 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.7 | 2.0 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.7 | 2.0 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.7 | 3.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.7 | 2.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.7 | 2.6 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.7 | 2.0 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.7 | 4.6 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.6 | 2.6 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.6 | 1.9 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.6 | 2.5 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.6 | 1.9 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.6 | 1.9 | GO:0043374 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.6 | 1.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.6 | 1.2 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.6 | 1.8 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.6 | 3.0 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.6 | 1.8 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.6 | 3.0 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.6 | 1.8 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.6 | 1.8 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.6 | 2.3 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.6 | 1.7 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.6 | 4.6 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.6 | 1.7 | GO:0010761 | fibroblast migration(GO:0010761) |
0.6 | 2.3 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.6 | 0.6 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.6 | 1.7 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.6 | 1.7 | GO:0051451 | myoblast migration(GO:0051451) |
0.6 | 0.6 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.6 | 1.1 | GO:0002707 | negative regulation of lymphocyte mediated immunity(GO:0002707) |
0.6 | 1.1 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.6 | 1.1 | GO:0070602 | centromeric sister chromatid cohesion(GO:0070601) regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.5 | 0.5 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) |
0.5 | 1.6 | GO:0016242 | regulation of macroautophagy(GO:0016241) negative regulation of macroautophagy(GO:0016242) |
0.5 | 1.6 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.5 | 1.1 | GO:0046398 | UDP-glucuronate biosynthetic process(GO:0006065) UDP-glucuronate metabolic process(GO:0046398) |
0.5 | 2.6 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.5 | 1.6 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.5 | 1.6 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.5 | 5.2 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.5 | 1.6 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
0.5 | 0.5 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
0.5 | 1.5 | GO:0000042 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.5 | 4.6 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.5 | 0.5 | GO:0071803 | regulation of podosome assembly(GO:0071801) positive regulation of podosome assembly(GO:0071803) |
0.5 | 0.5 | GO:0002467 | germinal center formation(GO:0002467) |
0.5 | 6.0 | GO:0031648 | protein destabilization(GO:0031648) |
0.5 | 0.5 | GO:0022403 | cell cycle phase(GO:0022403) |
0.5 | 1.0 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.5 | 0.5 | GO:0017085 | response to insecticide(GO:0017085) |
0.5 | 0.5 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.5 | 2.0 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.5 | 1.5 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.5 | 12.1 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.5 | 7.7 | GO:0060334 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.5 | 0.5 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.5 | 1.4 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.5 | 0.9 | GO:0033084 | regulation of immature T cell proliferation in thymus(GO:0033084) |
0.5 | 0.9 | GO:0010159 | specification of organ position(GO:0010159) |
0.5 | 2.4 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.5 | 1.9 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.5 | 1.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.5 | 1.4 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.5 | 2.3 | GO:0032876 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.5 | 0.9 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.5 | 0.9 | GO:0002507 | tolerance induction(GO:0002507) |
0.5 | 0.9 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.5 | 1.4 | GO:1901797 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.5 | 2.3 | GO:0021681 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.5 | 1.4 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.5 | 0.9 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.5 | 0.5 | GO:0006298 | mismatch repair(GO:0006298) |
0.5 | 0.9 | GO:0042511 | regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.5 | 3.2 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.4 | 1.3 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.4 | 1.8 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.4 | 0.9 | GO:0051834 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.4 | 2.7 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.4 | 1.3 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.4 | 0.4 | GO:0048539 | bone marrow development(GO:0048539) |
0.4 | 1.7 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.4 | 0.4 | GO:1902305 | regulation of sodium:proton antiporter activity(GO:0032415) regulation of sodium ion transmembrane transport(GO:1902305) regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.4 | 1.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.4 | 1.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.4 | 0.4 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.4 | 1.3 | GO:0043320 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.4 | 2.1 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.4 | 2.1 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.4 | 1.7 | GO:0051532 | NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
0.4 | 0.4 | GO:0042109 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.4 | 2.9 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.4 | 0.8 | GO:0034776 | response to histamine(GO:0034776) |
0.4 | 0.8 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.4 | 2.1 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.4 | 0.8 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.4 | 1.2 | GO:0045576 | mast cell activation(GO:0045576) |
0.4 | 1.6 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.4 | 0.8 | GO:0050686 | negative regulation of mRNA processing(GO:0050686) negative regulation of mRNA metabolic process(GO:1903312) |
0.4 | 1.2 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.4 | 0.8 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.4 | 4.4 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.4 | 0.4 | GO:0033032 | regulation of myeloid cell apoptotic process(GO:0033032) |
0.4 | 0.4 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.4 | 0.8 | GO:1901985 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.4 | 1.6 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.4 | 1.2 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) positive regulation of activation of Janus kinase activity(GO:0010536) |
0.4 | 3.6 | GO:0032456 | endocytic recycling(GO:0032456) |
0.4 | 1.6 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.4 | 0.8 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.4 | 0.8 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.4 | 2.0 | GO:0048532 | anatomical structure arrangement(GO:0048532) |
0.4 | 2.4 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.4 | 1.6 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.4 | 0.4 | GO:0002920 | regulation of humoral immune response(GO:0002920) |
0.4 | 1.9 | GO:0048617 | embryonic foregut morphogenesis(GO:0048617) |
0.4 | 0.4 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.4 | 3.1 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.4 | 1.9 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.4 | 1.1 | GO:0046668 | retinal cell programmed cell death(GO:0046666) regulation of retinal cell programmed cell death(GO:0046668) |
0.4 | 0.4 | GO:0052251 | induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) |
0.4 | 0.4 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.4 | 1.1 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.4 | 0.4 | GO:0044843 | G1/S transition of mitotic cell cycle(GO:0000082) cell cycle G1/S phase transition(GO:0044843) |
0.4 | 0.4 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.4 | 1.5 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.4 | 0.4 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.4 | 0.7 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.4 | 4.7 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.4 | 5.4 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.4 | 0.7 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) positive regulation of lamellipodium organization(GO:1902745) |
0.4 | 0.7 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.4 | 1.1 | GO:0032506 | cytokinetic process(GO:0032506) |
0.4 | 0.4 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.4 | 1.1 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.4 | 0.7 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.4 | 0.7 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.4 | 1.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 0.3 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.3 | 1.4 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.3 | 1.0 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.3 | 1.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.3 | 1.4 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.3 | 1.0 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.3 | 2.4 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.3 | 1.0 | GO:0043276 | anoikis(GO:0043276) |
0.3 | 1.0 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.3 | 0.3 | GO:0031345 | negative regulation of cell projection organization(GO:0031345) |
0.3 | 0.3 | GO:0032743 | positive regulation of interleukin-2 production(GO:0032743) |
0.3 | 2.3 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.3 | 0.3 | GO:1904035 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.3 | 1.3 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.3 | 1.3 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.3 | 4.0 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.3 | 1.6 | GO:0006337 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.3 | 1.3 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.3 | 1.6 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.3 | 1.3 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.3 | 0.7 | GO:0072678 | T cell migration(GO:0072678) |
0.3 | 5.9 | GO:0046677 | response to antibiotic(GO:0046677) |
0.3 | 0.3 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.3 | 0.7 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.3 | 1.6 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.3 | 1.6 | GO:0072583 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.3 | 5.2 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.3 | 0.3 | GO:0034063 | stress granule assembly(GO:0034063) |
0.3 | 1.3 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.3 | 1.6 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.3 | 1.6 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.3 | 0.3 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) positive regulation of cardiocyte differentiation(GO:1905209) |
0.3 | 0.3 | GO:2001021 | negative regulation of response to DNA damage stimulus(GO:2001021) |
0.3 | 0.6 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.3 | 1.6 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.3 | 0.3 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.3 | 0.3 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.3 | 0.9 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.3 | 1.6 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.3 | 1.3 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.3 | 0.9 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.3 | 0.3 | GO:0051445 | regulation of meiotic nuclear division(GO:0040020) regulation of meiotic cell cycle(GO:0051445) |
0.3 | 8.4 | GO:1901185 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.3 | 0.6 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.3 | 1.2 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.3 | 0.6 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.3 | 0.9 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.3 | 0.9 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.3 | 1.2 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.3 | 3.6 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.3 | 0.3 | GO:0007006 | mitochondrial membrane organization(GO:0007006) |
0.3 | 0.6 | GO:0050832 | defense response to fungus(GO:0050832) |
0.3 | 1.5 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.3 | 0.3 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
0.3 | 0.9 | GO:0034626 | fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.3 | 1.5 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.3 | 1.8 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.3 | 2.1 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.3 | 0.9 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.3 | 1.2 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.3 | 2.1 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.3 | 1.2 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.3 | 1.5 | GO:0030183 | B cell differentiation(GO:0030183) |
0.3 | 4.5 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.3 | 2.7 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.3 | 1.5 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.3 | 0.3 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.3 | 6.5 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.3 | 0.3 | GO:0072224 | metanephric glomerulus development(GO:0072224) metanephric glomerulus vasculature development(GO:0072239) |
0.3 | 0.6 | GO:1904358 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.3 | 0.9 | GO:0070265 | necrotic cell death(GO:0070265) |
0.3 | 0.9 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.3 | 0.9 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.3 | 0.9 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.3 | 4.1 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.3 | 0.6 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.3 | 0.9 | GO:0031334 | positive regulation of protein complex assembly(GO:0031334) |
0.3 | 0.6 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.3 | 0.9 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.3 | 0.3 | GO:0002823 | negative regulation of adaptive immune response(GO:0002820) negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002823) |
0.3 | 1.2 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.3 | 0.6 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.3 | 1.7 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.3 | 1.4 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.3 | 0.3 | GO:0014055 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
0.3 | 0.6 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.3 | 1.7 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.3 | 1.4 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.3 | 0.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.3 | 0.3 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.3 | 0.3 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.3 | 2.2 | GO:0098927 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.3 | 2.2 | GO:0006465 | signal peptide processing(GO:0006465) |
0.3 | 0.3 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.3 | 0.8 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.3 | 0.8 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.3 | 5.8 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.3 | 1.4 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.3 | 0.8 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.3 | 1.9 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.3 | 1.6 | GO:2000257 | regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
0.3 | 0.3 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.3 | 1.6 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.3 | 0.5 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.3 | 0.8 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.3 | 0.8 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.3 | 0.5 | GO:0072216 | positive regulation of metanephros development(GO:0072216) |
0.3 | 0.8 | GO:0097501 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
0.3 | 0.5 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.3 | 13.5 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.3 | 1.3 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.3 | 0.5 | GO:0043393 | regulation of protein binding(GO:0043393) |
0.3 | 0.8 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.3 | 0.8 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.3 | 4.0 | GO:1900181 | negative regulation of protein import into nucleus(GO:0042308) negative regulation of protein localization to nucleus(GO:1900181) negative regulation of protein import(GO:1904590) |
0.3 | 0.8 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.3 | 0.8 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.3 | 0.8 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.3 | 0.5 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.3 | 6.3 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.3 | 4.0 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 2.9 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.3 | 0.3 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.3 | 1.6 | GO:0032367 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.3 | 0.5 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.3 | 0.8 | GO:0031343 | positive regulation of cell killing(GO:0031343) |
0.3 | 0.3 | GO:0022613 | ribonucleoprotein complex biogenesis(GO:0022613) |
0.3 | 0.3 | GO:0048478 | replication fork protection(GO:0048478) |
0.3 | 0.5 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.3 | 0.3 | GO:0010921 | regulation of phosphatase activity(GO:0010921) |
0.3 | 0.8 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.3 | 1.0 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.3 | 1.0 | GO:1903320 | regulation of protein modification by small protein conjugation or removal(GO:1903320) |
0.3 | 0.3 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.3 | 1.3 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.3 | 1.3 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.3 | 0.3 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
0.3 | 0.3 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.3 | 0.5 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.3 | 0.8 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.3 | 0.5 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.3 | 0.8 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 0.2 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.2 | 0.7 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.2 | 0.7 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.2 | 0.5 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.2 | 1.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 0.5 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.2 | 1.2 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.2 | 1.7 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.2 | 10.6 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.2 | 0.7 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.2 | 1.2 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.2 | 3.8 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.2 | 0.2 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.2 | 0.5 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.2 | 0.7 | GO:0010823 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.2 | 0.2 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.2 | 3.8 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.2 | 0.5 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.2 | 1.0 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.2 | 0.7 | GO:0001757 | somite specification(GO:0001757) |
0.2 | 0.7 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.2 | 1.9 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.2 | 0.5 | GO:0019730 | antimicrobial humoral response(GO:0019730) antibacterial humoral response(GO:0019731) |
0.2 | 0.2 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
0.2 | 0.5 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.2 | 0.9 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.2 | 0.7 | GO:0051182 | coenzyme transport(GO:0051182) |
0.2 | 2.8 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.2 | 2.3 | GO:0007379 | segment specification(GO:0007379) |
0.2 | 0.5 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.2 | 0.5 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.2 | 0.5 | GO:0000089 | mitotic metaphase(GO:0000089) |
0.2 | 1.2 | GO:0009855 | specification of symmetry(GO:0009799) determination of bilateral symmetry(GO:0009855) |
0.2 | 4.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 1.6 | GO:0006983 | ER overload response(GO:0006983) |
0.2 | 1.8 | GO:0006554 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.2 | 0.9 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 1.4 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.2 | 0.9 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.2 | 0.2 | GO:0046348 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.2 | 2.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.2 | 6.4 | GO:0006903 | vesicle targeting(GO:0006903) |
0.2 | 0.7 | GO:0045056 | transcytosis(GO:0045056) |
0.2 | 0.2 | GO:0035588 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.2 | 1.4 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.2 | 0.7 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.2 | 0.2 | GO:0044848 | biological phase(GO:0044848) |
0.2 | 0.9 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.2 | 0.5 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.2 | 1.6 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.2 | 0.2 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.2 | 0.4 | GO:0032649 | regulation of interferon-gamma production(GO:0032649) |
0.2 | 0.7 | GO:0009301 | snRNA transcription(GO:0009301) |
0.2 | 0.2 | GO:0034143 | regulation of toll-like receptor 4 signaling pathway(GO:0034143) |
0.2 | 0.4 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.2 | 0.7 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 0.4 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
0.2 | 0.4 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.2 | 0.4 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.2 | 0.4 | GO:0032730 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.2 | 0.7 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.2 | 0.4 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.2 | 0.9 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) natural killer cell mediated cytotoxicity(GO:0042267) |
0.2 | 0.2 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.2 | 0.4 | GO:1904181 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.2 | 0.2 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.2 | 0.2 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.2 | 0.2 | GO:0052572 | microglial cell activation involved in immune response(GO:0002282) response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
0.2 | 0.6 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.2 | 1.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.2 | 0.6 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.2 | 0.6 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.2 | 1.9 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 0.8 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.2 | 0.4 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.2 | 2.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.2 | 1.0 | GO:0044349 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.2 | 0.8 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 0.2 | GO:0061339 | establishment of apical/basal cell polarity(GO:0035089) establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.2 | 0.4 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.2 | 0.6 | GO:0001706 | endoderm formation(GO:0001706) |
0.2 | 0.4 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.2 | 0.6 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.2 | 0.6 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.2 | 1.2 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.2 | 3.9 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.2 | 0.4 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.2 | 0.2 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.2 | 0.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.2 | 0.6 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.2 | 1.6 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.2 | 0.4 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.2 | 0.2 | GO:0001832 | blastocyst growth(GO:0001832) |
0.2 | 0.2 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.2 | 0.4 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.2 | 0.6 | GO:0043967 | histone H4 acetylation(GO:0043967) |
0.2 | 0.4 | GO:0009405 | pathogenesis(GO:0009405) |
0.2 | 0.4 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.2 | 1.2 | GO:1904031 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.2 | 3.0 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.2 | 0.2 | GO:0051608 | histamine transport(GO:0051608) |
0.2 | 0.8 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.2 | 0.4 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.2 | 0.6 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.2 | 14.3 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.2 | 0.2 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.2 | 0.4 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.2 | 0.2 | GO:0051322 | anaphase(GO:0051322) |
0.2 | 0.6 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.2 | 0.2 | GO:0031223 | auditory behavior(GO:0031223) |
0.2 | 0.6 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.2 | 1.4 | GO:2000134 | negative regulation of cell cycle G1/S phase transition(GO:1902807) negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.2 | 0.2 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.2 | 0.2 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.2 | 0.8 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
0.2 | 1.0 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.2 | 2.6 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.2 | 0.8 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 1.6 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.2 | 0.8 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.2 | 0.2 | GO:0045061 | thymic T cell selection(GO:0045061) |
0.2 | 0.8 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.2 | 3.1 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.2 | 1.0 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.2 | 0.2 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.2 | 0.6 | GO:0010447 | response to acidic pH(GO:0010447) |
0.2 | 0.4 | GO:0022409 | positive regulation of cell-cell adhesion(GO:0022409) |
0.2 | 12.8 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.2 | 1.3 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
0.2 | 0.2 | GO:0071028 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.2 | 0.6 | GO:0048069 | eye pigmentation(GO:0048069) |
0.2 | 3.6 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.2 | 0.6 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.2 | 0.4 | GO:0060179 | male courtship behavior(GO:0008049) male mating behavior(GO:0060179) |
0.2 | 0.4 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
0.2 | 0.4 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.2 | 0.4 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.2 | 0.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.2 | 0.6 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.2 | 0.2 | GO:0098656 | anion transmembrane transport(GO:0098656) |
0.2 | 0.9 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.2 | 0.2 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.2 | 1.9 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.2 | 0.4 | GO:0000422 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.2 | 0.6 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.2 | 0.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 9.1 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.2 | 0.7 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.2 | 0.4 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 0.4 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.2 | 5.7 | GO:0051028 | mRNA transport(GO:0051028) |
0.2 | 0.6 | GO:0071305 | cellular response to vitamin D(GO:0071305) |
0.2 | 0.2 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
0.2 | 1.1 | GO:0048535 | lymph node development(GO:0048535) |
0.2 | 0.4 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.2 | 0.5 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.2 | 0.5 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.2 | 1.8 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.2 | 0.9 | GO:0006839 | mitochondrial transport(GO:0006839) |
0.2 | 2.9 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.2 | 0.2 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.2 | 1.4 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 0.9 | GO:0030856 | regulation of epithelial cell differentiation(GO:0030856) |
0.2 | 1.8 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.2 | 0.2 | GO:0031646 | positive regulation of neurological system process(GO:0031646) |
0.2 | 1.1 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 2.0 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 0.7 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.2 | 4.8 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.2 | 0.2 | GO:0016556 | mRNA modification(GO:0016556) |
0.2 | 0.4 | GO:0007144 | female meiosis I(GO:0007144) |
0.2 | 1.6 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.2 | 0.2 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.2 | 0.4 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.2 | 0.4 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.2 | 0.2 | GO:0009151 | purine deoxyribonucleotide metabolic process(GO:0009151) purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
0.2 | 0.9 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.2 | 0.7 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.2 | 0.4 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.2 | 1.2 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.2 | 0.5 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.2 | 0.5 | GO:0002456 | T cell mediated immunity(GO:0002456) |
0.2 | 0.2 | GO:0035329 | hippo signaling(GO:0035329) |
0.2 | 0.2 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.2 | 0.5 | GO:0071569 | protein ufmylation(GO:0071569) |
0.2 | 0.5 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.2 | 0.3 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.2 | 0.3 | GO:0035050 | embryonic heart tube development(GO:0035050) |
0.2 | 0.2 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.2 | 0.3 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.2 | 0.5 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.2 | 0.2 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.2 | 0.7 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.2 | 2.9 | GO:2000058 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000058) |
0.2 | 0.5 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.2 | 0.2 | GO:0015904 | tetracycline transport(GO:0015904) |
0.2 | 0.3 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.2 | 0.7 | GO:0046479 | glycosylceramide catabolic process(GO:0046477) glycosphingolipid catabolic process(GO:0046479) |
0.2 | 1.0 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.2 | 0.2 | GO:0032770 | positive regulation of monooxygenase activity(GO:0032770) |
0.2 | 0.7 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.2 | 38.2 | GO:0006397 | mRNA processing(GO:0006397) |
0.2 | 0.5 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.2 | 1.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.2 | 2.3 | GO:0035637 | transmission of nerve impulse(GO:0019226) multicellular organismal signaling(GO:0035637) |
0.2 | 0.2 | GO:1900121 | regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) |
0.2 | 0.5 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 0.5 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.2 | 1.0 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.2 | 0.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.2 | 2.7 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.2 | 1.7 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.2 | 1.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.2 | 0.8 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 0.3 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.2 | 4.6 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.2 | 1.5 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.2 | 0.5 | GO:0006301 | postreplication repair(GO:0006301) |
0.2 | 1.0 | GO:0031529 | ruffle organization(GO:0031529) |
0.2 | 0.5 | GO:0006325 | chromatin organization(GO:0006325) |
0.2 | 0.5 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.2 | 0.2 | GO:0022406 | membrane docking(GO:0022406) |
0.2 | 0.5 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.2 | 0.3 | GO:0010506 | regulation of autophagy(GO:0010506) |
0.2 | 0.8 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.2 | 0.2 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.2 | 1.0 | GO:0042423 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.2 | 0.3 | GO:0001840 | neural plate morphogenesis(GO:0001839) neural plate development(GO:0001840) |
0.2 | 7.9 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.2 | 1.8 | GO:0045730 | respiratory burst(GO:0045730) |
0.2 | 0.2 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.2 | 0.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 0.5 | GO:0006997 | nucleus organization(GO:0006997) |
0.2 | 1.4 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 1.4 | GO:0006862 | nucleotide transport(GO:0006862) |
0.2 | 1.8 | GO:1903037 | regulation of T cell activation(GO:0050863) regulation of leukocyte cell-cell adhesion(GO:1903037) |
0.2 | 20.7 | GO:0016568 | chromatin modification(GO:0016568) |
0.2 | 0.2 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.2 | 1.1 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.2 | 4.4 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.2 | 0.6 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.2 | 0.5 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.2 | 0.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 1.1 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.2 | 0.3 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.2 | 0.5 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.2 | 2.3 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.2 | 0.5 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.2 | 0.9 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.2 | 0.3 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.2 | 0.3 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 0.5 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.2 | 0.2 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.2 | 0.5 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.2 | 6.7 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 0.5 | GO:0048641 | regulation of skeletal muscle tissue development(GO:0048641) |
0.1 | 1.3 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 0.7 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.3 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.1 | 0.6 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.1 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.1 | 0.1 | GO:0006625 | protein targeting to peroxisome(GO:0006625) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.1 | 0.1 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.7 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.1 | 1.5 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.3 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.1 | 3.6 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.1 | 0.1 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.3 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.1 | 0.3 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.7 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.1 | 0.7 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.1 | 0.7 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) regulation of neurotransmitter transport(GO:0051588) |
0.1 | 0.7 | GO:0045008 | depyrimidination(GO:0045008) |
0.1 | 1.6 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 0.1 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.1 | 3.3 | GO:0072512 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.1 | 0.3 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.1 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.1 | 0.3 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 1.3 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 1.0 | GO:0042255 | ribosome assembly(GO:0042255) |
0.1 | 1.0 | GO:0045010 | actin nucleation(GO:0045010) |
0.1 | 1.9 | GO:0009303 | rRNA transcription(GO:0009303) ncRNA transcription(GO:0098781) |
0.1 | 0.1 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
0.1 | 0.1 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.1 | 1.0 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.1 | 0.1 | GO:0048640 | negative regulation of developmental growth(GO:0048640) |
0.1 | 3.2 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.1 | 0.4 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
0.1 | 0.3 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
0.1 | 0.1 | GO:0044773 | mitotic DNA damage checkpoint(GO:0044773) |
0.1 | 1.0 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.1 | 0.1 | GO:0001825 | blastocyst formation(GO:0001825) |
0.1 | 0.1 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.1 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 0.3 | GO:0032202 | telomere assembly(GO:0032202) telomere formation via telomerase(GO:0032203) |
0.1 | 0.4 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.5 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.1 | GO:0016045 | detection of bacterium(GO:0016045) |
0.1 | 9.8 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.1 | 0.1 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.1 | 0.9 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 1.2 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 0.3 | GO:0016458 | gene silencing(GO:0016458) |
0.1 | 0.3 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
0.1 | 0.8 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.1 | 0.5 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.1 | 0.1 | GO:0032200 | telomere organization(GO:0032200) |
0.1 | 0.5 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.1 | 0.8 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.1 | 0.3 | GO:0021903 | rostrocaudal neural tube patterning(GO:0021903) |
0.1 | 1.0 | GO:0000050 | urea cycle(GO:0000050) |
0.1 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.6 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 1.2 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.1 | 0.5 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.3 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.5 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 0.1 | GO:0035587 | purinergic receptor signaling pathway(GO:0035587) purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 3.6 | GO:0034339 | obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
0.1 | 0.1 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.4 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.1 | 9.5 | GO:0006415 | translational termination(GO:0006415) |
0.1 | 0.5 | GO:0002098 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.1 | 0.9 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.1 | 0.1 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 1.4 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 0.1 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.1 | 0.3 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 1.6 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.1 | GO:1902117 | positive regulation of organelle assembly(GO:1902117) |
0.1 | 0.2 | GO:0006309 | DNA catabolic process, endonucleolytic(GO:0000737) apoptotic DNA fragmentation(GO:0006309) |
0.1 | 1.0 | GO:0015872 | dopamine transport(GO:0015872) |
0.1 | 1.9 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.1 | 0.4 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.1 | 0.7 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
0.1 | 0.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.4 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 0.4 | GO:0002076 | osteoblast development(GO:0002076) |
0.1 | 4.7 | GO:0000087 | mitotic M phase(GO:0000087) |
0.1 | 0.4 | GO:0070295 | renal water absorption(GO:0070295) |
0.1 | 0.2 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.1 | 0.1 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.1 | 0.1 | GO:0051095 | regulation of helicase activity(GO:0051095) |
0.1 | 0.4 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.2 | GO:0001738 | morphogenesis of a polarized epithelium(GO:0001738) |
0.1 | 0.2 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.1 | 0.4 | GO:0044070 | regulation of anion transport(GO:0044070) |
0.1 | 0.7 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.6 | GO:1901862 | negative regulation of striated muscle tissue development(GO:0045843) negative regulation of muscle tissue development(GO:1901862) |
0.1 | 0.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.4 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.1 | 0.1 | GO:2000300 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 0.4 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.1 | 0.6 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 1.1 | GO:0048705 | skeletal system morphogenesis(GO:0048705) |
0.1 | 0.1 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.1 | 0.4 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 0.1 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.1 | 1.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 1.4 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.1 | 0.1 | GO:0032402 | melanosome transport(GO:0032402) |
0.1 | 0.8 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 25.1 | GO:0006412 | translation(GO:0006412) |
0.1 | 1.0 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.1 | 0.2 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 0.1 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.1 | 0.1 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 1.6 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.3 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.6 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.1 | 0.1 | GO:0035270 | endocrine system development(GO:0035270) |
0.1 | 13.8 | GO:0051603 | proteolysis involved in cellular protein catabolic process(GO:0051603) |
0.1 | 1.1 | GO:0001510 | RNA methylation(GO:0001510) |
0.1 | 0.2 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.1 | 0.6 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.1 | 1.9 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 0.3 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.1 | 0.8 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.1 | 1.9 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.1 | 0.4 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.2 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.3 | GO:0030033 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.1 | 0.1 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.3 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.1 | 0.8 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.1 | 0.6 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.6 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 0.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.3 | GO:0050770 | regulation of axonogenesis(GO:0050770) |
0.1 | 0.2 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.1 | 0.8 | GO:0051928 | positive regulation of calcium ion transport(GO:0051928) |
0.1 | 1.2 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 1.9 | GO:0051607 | defense response to virus(GO:0051607) |
0.1 | 0.4 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.1 | 0.2 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.1 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.1 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.6 | GO:0051298 | centrosome duplication(GO:0051298) |
0.1 | 0.8 | GO:0006282 | regulation of DNA repair(GO:0006282) |
0.1 | 0.1 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.1 | 1.6 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.3 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.1 | 0.4 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.1 | 0.3 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.1 | 2.1 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 0.1 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 4.4 | GO:0008033 | tRNA processing(GO:0008033) |
0.1 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.3 | GO:0043441 | acetoacetic acid biosynthetic process(GO:0043441) |
0.1 | 0.7 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.6 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 2.2 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.1 | 0.1 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.1 | 0.8 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.1 | 0.8 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
0.1 | 0.1 | GO:1990778 | protein localization to plasma membrane(GO:0072659) protein localization to cell periphery(GO:1990778) |
0.1 | 0.1 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
0.1 | 0.4 | GO:0035121 | obsolete tail morphogenesis(GO:0035121) |
0.1 | 1.3 | GO:0016236 | macroautophagy(GO:0016236) |
0.1 | 0.4 | GO:0007632 | visual behavior(GO:0007632) |
0.1 | 0.1 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.1 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.1 | 0.3 | GO:2000021 | regulation of ion homeostasis(GO:2000021) |
0.1 | 0.6 | GO:0009409 | response to cold(GO:0009409) |
0.1 | 0.4 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 0.5 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.1 | GO:0018119 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.1 | 1.9 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 2.0 | GO:0072655 | establishment of protein localization to mitochondrion(GO:0072655) |
0.1 | 0.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.6 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.1 | 0.3 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 0.1 | GO:0045934 | negative regulation of nucleobase-containing compound metabolic process(GO:0045934) |
0.1 | 1.2 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.1 | 0.2 | GO:0072111 | cell proliferation involved in kidney development(GO:0072111) |
0.1 | 1.6 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.1 | 0.3 | GO:0045666 | positive regulation of neuron differentiation(GO:0045666) |
0.1 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.6 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.2 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 0.4 | GO:0007530 | sex determination(GO:0007530) |
0.1 | 1.0 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.1 | 0.1 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.1 | 0.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 0.1 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.1 | 0.6 | GO:0006959 | humoral immune response(GO:0006959) |
0.1 | 0.4 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.1 | GO:0015919 | peroxisomal membrane transport(GO:0015919) |
0.1 | 0.2 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 0.7 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.2 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.1 | 0.4 | GO:0010608 | posttranscriptional regulation of gene expression(GO:0010608) |
0.1 | 0.3 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
0.1 | 0.2 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.1 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.1 | 0.1 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.1 | 0.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.1 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
0.1 | 0.2 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.9 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.1 | 0.6 | GO:0031647 | regulation of protein stability(GO:0031647) |
0.1 | 0.1 | GO:0045823 | positive regulation of heart contraction(GO:0045823) |
0.1 | 0.1 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.1 | 0.3 | GO:0001881 | receptor recycling(GO:0001881) |
0.1 | 0.4 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.1 | 0.1 | GO:0099565 | regulation of postsynaptic membrane potential(GO:0060078) chemical synaptic transmission, postsynaptic(GO:0099565) |
0.1 | 0.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 10.2 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.4 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.4 | GO:0071356 | cellular response to tumor necrosis factor(GO:0071356) |
0.1 | 0.5 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.1 | 0.1 | GO:0072202 | cell differentiation involved in metanephros development(GO:0072202) |
0.1 | 0.2 | GO:0071482 | cellular response to light stimulus(GO:0071482) |
0.1 | 0.1 | GO:0007494 | midgut development(GO:0007494) |
0.1 | 0.4 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.3 | GO:0008347 | glial cell migration(GO:0008347) |
0.1 | 1.2 | GO:0022616 | DNA strand elongation(GO:0022616) |
0.1 | 14.6 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.1 | 0.1 | GO:0006304 | DNA modification(GO:0006304) |
0.1 | 2.6 | GO:0044782 | cilium organization(GO:0044782) |
0.1 | 0.6 | GO:0007031 | peroxisome organization(GO:0007031) |
0.1 | 0.1 | GO:0060992 | response to fungicide(GO:0060992) |
0.1 | 0.4 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.1 | 0.1 | GO:0010634 | positive regulation of epithelial cell migration(GO:0010634) |
0.1 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 1.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.6 | GO:0001947 | heart looping(GO:0001947) embryonic heart tube morphogenesis(GO:0003143) determination of heart left/right asymmetry(GO:0061371) |
0.1 | 0.2 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.1 | 0.3 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.4 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.6 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 1.2 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.1 | 0.1 | GO:0043243 | positive regulation of protein complex disassembly(GO:0043243) positive regulation of protein depolymerization(GO:1901881) |
0.1 | 3.5 | GO:0016072 | rRNA metabolic process(GO:0016072) |
0.1 | 0.3 | GO:0043523 | regulation of neuron apoptotic process(GO:0043523) regulation of neuron death(GO:1901214) |
0.1 | 0.5 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.2 | GO:0033133 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.3 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.1 | 0.1 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.2 | GO:0051593 | response to folic acid(GO:0051593) |
0.1 | 0.2 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.1 | GO:0015811 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.1 | 0.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.6 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.1 | 0.2 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.1 | 1.1 | GO:0051258 | protein polymerization(GO:0051258) |
0.1 | 0.1 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.1 | 0.7 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.2 | GO:0030278 | regulation of ossification(GO:0030278) |
0.1 | 0.2 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
0.1 | 0.4 | GO:0002209 | behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) |
0.1 | 0.2 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.1 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.1 | 0.2 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.5 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.1 | 0.2 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) organelle disassembly(GO:1903008) |
0.1 | 0.2 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.1 | 0.1 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) |
0.1 | 0.2 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.2 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.1 | 0.7 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.2 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.1 | 0.4 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.9 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.1 | 1.2 | GO:0015992 | proton transport(GO:0015992) |
0.1 | 0.2 | GO:1900087 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.1 | 0.7 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.3 | GO:0010669 | epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.4 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.1 | 0.6 | GO:0060678 | dichotomous subdivision of terminal units involved in ureteric bud branching(GO:0060678) |
0.1 | 0.7 | GO:0034762 | regulation of transmembrane transport(GO:0034762) |
0.1 | 0.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.6 | GO:0043524 | negative regulation of neuron apoptotic process(GO:0043524) negative regulation of neuron death(GO:1901215) |
0.1 | 0.2 | GO:1903729 | regulation of plasma membrane organization(GO:1903729) |
0.1 | 0.1 | GO:0032409 | regulation of transporter activity(GO:0032409) |
0.1 | 0.3 | GO:0050974 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.1 | 0.2 | GO:0010907 | positive regulation of glucose metabolic process(GO:0010907) |
0.1 | 0.7 | GO:0007059 | chromosome segregation(GO:0007059) |
0.1 | 0.2 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.1 | 0.1 | GO:0031623 | receptor internalization(GO:0031623) |
0.1 | 0.4 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.1 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 1.6 | GO:0006302 | double-strand break repair(GO:0006302) |
0.1 | 0.5 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.1 | 0.4 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.9 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.1 | 0.2 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.1 | GO:0009179 | purine nucleoside diphosphate metabolic process(GO:0009135) purine ribonucleoside diphosphate metabolic process(GO:0009179) |
0.1 | 1.0 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.1 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 1.0 | GO:0001764 | neuron migration(GO:0001764) |
0.1 | 0.3 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.1 | 0.6 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.4 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.5 | GO:0016070 | RNA metabolic process(GO:0016070) |
0.1 | 0.3 | GO:0071331 | cellular response to monosaccharide stimulus(GO:0071326) cellular response to hexose stimulus(GO:0071331) cellular response to glucose stimulus(GO:0071333) |
0.1 | 0.1 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 0.1 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.1 | 0.1 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.1 | 0.1 | GO:0021891 | olfactory bulb interneuron differentiation(GO:0021889) olfactory bulb interneuron development(GO:0021891) |
0.1 | 0.1 | GO:0002329 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.1 | 0.8 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
0.1 | 0.4 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.1 | 0.1 | GO:1903725 | regulation of phospholipid metabolic process(GO:1903725) |
0.1 | 1.5 | GO:0060041 | retina development in camera-type eye(GO:0060041) |
0.1 | 0.3 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.1 | 1.6 | GO:0034340 | response to type I interferon(GO:0034340) |
0.1 | 1.0 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.1 | 0.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 0.7 | GO:0055067 | monovalent inorganic cation homeostasis(GO:0055067) |
0.1 | 0.1 | GO:0021766 | hippocampus development(GO:0021766) |
0.1 | 0.1 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.1 | 0.8 | GO:0001906 | cell killing(GO:0001906) |
0.1 | 0.1 | GO:0015791 | polyol transport(GO:0015791) |
0.1 | 0.1 | GO:0051552 | flavone metabolic process(GO:0051552) |
0.1 | 0.1 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.1 | 0.1 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.1 | 0.2 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.1 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.1 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 0.6 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.1 | 1.1 | GO:0006396 | RNA processing(GO:0006396) |
0.1 | 0.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.2 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.3 | GO:0007498 | mesoderm development(GO:0007498) |
0.1 | 0.2 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.1 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 0.1 | GO:0072078 | branching involved in ureteric bud morphogenesis(GO:0001658) ureteric bud morphogenesis(GO:0060675) nephron tubule morphogenesis(GO:0072078) mesonephric tubule morphogenesis(GO:0072171) |
0.1 | 0.6 | GO:0030317 | sperm motility(GO:0030317) |
0.1 | 0.2 | GO:0017158 | regulation of calcium ion-dependent exocytosis(GO:0017158) |
0.1 | 0.7 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 2.0 | GO:0008154 | actin polymerization or depolymerization(GO:0008154) |
0.1 | 0.4 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 1.0 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 0.1 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
0.1 | 0.1 | GO:0051961 | negative regulation of nervous system development(GO:0051961) |
0.1 | 0.7 | GO:0048477 | oogenesis(GO:0048477) |
0.1 | 5.3 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.1 | 0.1 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.1 | 0.1 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.1 | 0.7 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.1 | GO:0019827 | stem cell population maintenance(GO:0019827) maintenance of cell number(GO:0098727) |
0.1 | 0.2 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.1 | 0.1 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.1 | 0.5 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) negative regulation of lyase activity(GO:0051350) |
0.1 | 1.8 | GO:0006913 | nucleocytoplasmic transport(GO:0006913) |
0.1 | 0.2 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.1 | 0.1 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.1 | 0.1 | GO:0046173 | polyol biosynthetic process(GO:0046173) |
0.1 | 0.2 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 0.2 | GO:1990138 | axon extension(GO:0048675) neuron projection extension(GO:1990138) |
0.1 | 0.2 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.3 | GO:0070489 | T cell activation(GO:0042110) leukocyte aggregation(GO:0070486) T cell aggregation(GO:0070489) lymphocyte aggregation(GO:0071593) |
0.1 | 0.2 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.1 | 1.4 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.1 | 0.4 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.1 | 0.1 | GO:0048263 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.1 | 1.1 | GO:0007588 | excretion(GO:0007588) |
0.1 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.1 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.1 | 0.3 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.1 | 0.1 | GO:0090329 | regulation of DNA-dependent DNA replication(GO:0090329) |
0.1 | 1.6 | GO:0050796 | regulation of insulin secretion(GO:0050796) |
0.1 | 0.1 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 0.1 | GO:0060606 | tube closure(GO:0060606) |
0.1 | 0.1 | GO:0090398 | cellular senescence(GO:0090398) |
0.1 | 0.1 | GO:0015838 | quaternary ammonium group transport(GO:0015697) amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
0.1 | 0.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.1 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.1 | 0.1 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.1 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.1 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 0.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.4 | GO:0006833 | water transport(GO:0006833) |
0.1 | 0.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 1.1 | GO:0009583 | detection of light stimulus(GO:0009583) |
0.1 | 0.1 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.1 | 0.1 | GO:0072498 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.1 | 0.1 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.1 | 0.1 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.1 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) positive regulation of response to cytokine stimulus(GO:0060760) |
0.1 | 0.1 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.1 | 0.1 | GO:2000106 | regulation of leukocyte apoptotic process(GO:2000106) |
0.1 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.1 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.0 | 0.0 | GO:0090026 | monocyte chemotaxis(GO:0002548) regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.1 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.0 | GO:1903828 | negative regulation of cellular protein localization(GO:1903828) |
0.0 | 2.1 | GO:0009615 | response to virus(GO:0009615) |
0.0 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.0 | GO:0048867 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.0 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.2 | GO:0043526 | obsolete neuroprotection(GO:0043526) |
0.0 | 0.0 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.0 | 0.7 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.1 | GO:0007613 | memory(GO:0007613) |
0.0 | 0.6 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
0.0 | 0.1 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.0 | 0.0 | GO:1903902 | positive regulation of viral process(GO:0048524) positive regulation of viral life cycle(GO:1903902) |
0.0 | 0.0 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.0 | 0.0 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.4 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.0 | 0.0 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.2 | GO:0043543 | protein acylation(GO:0043543) |
0.0 | 0.2 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.0 | GO:0010812 | negative regulation of cell-substrate adhesion(GO:0010812) |
0.0 | 3.3 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.0 | 9.6 | GO:0012501 | programmed cell death(GO:0012501) |
0.0 | 0.1 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.0 | 0.0 | GO:0006537 | glutamate biosynthetic process(GO:0006537) proline metabolic process(GO:0006560) proline catabolic process(GO:0006562) |
0.0 | 0.1 | GO:0010458 | exit from mitosis(GO:0010458) |
0.0 | 0.2 | GO:0009416 | response to light stimulus(GO:0009416) |
0.0 | 0.3 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.3 | GO:0006479 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.0 | 0.3 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.1 | GO:0015853 | purine nucleobase transport(GO:0006863) adenine transport(GO:0015853) |
0.0 | 0.1 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 2.4 | GO:0050776 | regulation of immune response(GO:0050776) |
0.0 | 0.3 | GO:0046849 | bone remodeling(GO:0046849) |
0.0 | 0.2 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.0 | 0.0 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.0 | 0.9 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.2 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.0 | 46.3 | GO:0032774 | RNA biosynthetic process(GO:0032774) |
0.0 | 0.0 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.1 | GO:0070570 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.0 | 0.2 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.0 | 0.2 | GO:0006101 | citrate metabolic process(GO:0006101) tricarboxylic acid metabolic process(GO:0072350) |
0.0 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 1.4 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.0 | 0.1 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.0 | 1.4 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.0 | 0.3 | GO:0006200 | obsolete ATP catabolic process(GO:0006200) |
0.0 | 0.2 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
0.0 | 0.1 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.0 | 0.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.0 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 0.1 | GO:0051324 | prophase(GO:0051324) |
0.0 | 0.1 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.0 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.0 | 0.3 | GO:0009408 | response to heat(GO:0009408) |
0.0 | 0.1 | GO:1901070 | guanosine-containing compound biosynthetic process(GO:1901070) |
0.0 | 0.2 | GO:0000910 | cytokinesis(GO:0000910) |
0.0 | 0.0 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.0 | 1.2 | GO:0007017 | microtubule-based process(GO:0007017) |
0.0 | 0.2 | GO:0015800 | acidic amino acid transport(GO:0015800) |
0.0 | 0.1 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 0.0 | GO:1902653 | secondary alcohol biosynthetic process(GO:1902653) |
0.0 | 0.2 | GO:1901071 | glucosamine-containing compound metabolic process(GO:1901071) |
0.0 | 0.1 | GO:0036473 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.0 | 0.1 | GO:0055006 | cardiac cell development(GO:0055006) cardiac muscle cell development(GO:0055013) |
0.0 | 0.3 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.0 | 0.1 | GO:0017156 | calcium ion regulated exocytosis(GO:0017156) |
0.0 | 0.1 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.1 | GO:0045766 | positive regulation of angiogenesis(GO:0045766) positive regulation of vasculature development(GO:1904018) |
0.0 | 0.1 | GO:0009223 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.0 | 0.0 | GO:0048483 | autonomic nervous system development(GO:0048483) |
0.0 | 0.0 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.0 | 0.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.0 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.0 | 0.2 | GO:0032259 | methylation(GO:0032259) |
0.0 | 8.9 | GO:0016310 | phosphorylation(GO:0016310) |
0.0 | 1.9 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.0 | 0.0 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.0 | 0.0 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.0 | 0.0 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.0 | 0.0 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.0 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.0 | 0.3 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.0 | 0.0 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.0 | 0.9 | GO:0007586 | digestion(GO:0007586) |
0.0 | 0.2 | GO:0046847 | filopodium assembly(GO:0046847) |
0.0 | 0.2 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.0 | 0.0 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.0 | 1.3 | GO:0006974 | cellular response to DNA damage stimulus(GO:0006974) |
0.0 | 0.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.2 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
0.0 | 0.0 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.0 | 1.0 | GO:0043413 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) |
0.0 | 0.0 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.0 | 0.0 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.0 | 0.0 | GO:0051187 | cofactor catabolic process(GO:0051187) |
0.0 | 0.0 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.0 | 0.0 | GO:0031427 | response to methotrexate(GO:0031427) |
0.0 | 4.6 | GO:0015031 | protein transport(GO:0015031) |
0.0 | 0.0 | GO:0009651 | response to salt stress(GO:0009651) |
0.0 | 0.0 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.0 | 0.0 | GO:1903319 | positive regulation of protein processing(GO:0010954) positive regulation of protein maturation(GO:1903319) |
0.0 | 0.1 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.0 | 0.0 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.0 | 0.2 | GO:1903046 | meiotic cell cycle(GO:0051321) meiotic cell cycle process(GO:1903046) |
0.0 | 0.0 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.0 | GO:0042471 | ear morphogenesis(GO:0042471) |
0.0 | 0.2 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.0 | 0.4 | GO:0008219 | cell death(GO:0008219) |
0.0 | 0.0 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.0 | 0.0 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 11.1 | GO:0001891 | phagocytic cup(GO:0001891) |
1.4 | 4.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.9 | 2.8 | GO:0072487 | MSL complex(GO:0072487) |
0.9 | 2.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.9 | 2.7 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.8 | 4.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.8 | 2.4 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.8 | 9.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.8 | 2.3 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.7 | 10.1 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.7 | 2.8 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.7 | 2.0 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.7 | 2.0 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.7 | 7.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.6 | 2.6 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.6 | 3.8 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.6 | 2.4 | GO:0005827 | polar microtubule(GO:0005827) |
0.6 | 3.4 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.5 | 4.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.5 | 1.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.5 | 2.5 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.5 | 0.5 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.5 | 0.5 | GO:0042555 | MCM complex(GO:0042555) |
0.5 | 4.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.5 | 1.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.5 | 0.9 | GO:0031932 | TORC2 complex(GO:0031932) |
0.5 | 4.7 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.5 | 2.8 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.5 | 3.7 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.5 | 1.8 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.5 | 1.8 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.5 | 1.8 | GO:0043218 | compact myelin(GO:0043218) |
0.5 | 1.8 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.5 | 0.5 | GO:0030496 | midbody(GO:0030496) |
0.4 | 2.2 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.4 | 1.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.4 | 2.6 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.4 | 2.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.4 | 4.7 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.4 | 1.6 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.4 | 2.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.4 | 1.2 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.4 | 0.8 | GO:0042583 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.4 | 3.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.4 | 2.3 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.4 | 1.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.4 | 4.2 | GO:0031519 | PcG protein complex(GO:0031519) |
0.4 | 2.3 | GO:0032590 | dendrite membrane(GO:0032590) |
0.4 | 1.9 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.4 | 2.2 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.4 | 2.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.4 | 11.9 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.4 | 2.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.4 | 1.8 | GO:0070695 | FHF complex(GO:0070695) |
0.4 | 4.9 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.4 | 3.5 | GO:0045120 | pronucleus(GO:0045120) |
0.4 | 3.9 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.3 | 0.3 | GO:0008278 | cohesin complex(GO:0008278) |
0.3 | 2.1 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.3 | 2.7 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.3 | 0.3 | GO:0044422 | organelle part(GO:0044422) |
0.3 | 2.9 | GO:0043209 | myelin sheath(GO:0043209) |
0.3 | 0.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.3 | 2.2 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.3 | 2.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.3 | 9.9 | GO:0005876 | spindle microtubule(GO:0005876) |
0.3 | 0.9 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.3 | 0.6 | GO:0031312 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of organelle membrane(GO:0031312) extrinsic component of endosome membrane(GO:0031313) |
0.3 | 0.9 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.3 | 0.3 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.3 | 3.0 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.3 | 0.9 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.3 | 0.9 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.3 | 0.6 | GO:0070552 | BRISC complex(GO:0070552) |
0.3 | 5.0 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.3 | 1.2 | GO:0001740 | Barr body(GO:0001740) |
0.3 | 5.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 2.3 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.3 | 0.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 0.5 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.3 | 1.1 | GO:0005667 | transcription factor complex(GO:0005667) |
0.3 | 1.6 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.3 | 2.7 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.3 | 8.4 | GO:0030175 | filopodium(GO:0030175) |
0.3 | 0.8 | GO:0001652 | granular component(GO:0001652) |
0.3 | 0.8 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.3 | 0.8 | GO:0071942 | XPC complex(GO:0071942) |
0.3 | 6.4 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.3 | 0.3 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 1.9 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.3 | 5.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.3 | 0.8 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.3 | 1.0 | GO:0030891 | VCB complex(GO:0030891) |
0.3 | 1.0 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.3 | 0.8 | GO:0016589 | NURF complex(GO:0016589) |
0.3 | 4.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.3 | 1.3 | GO:0000796 | condensin complex(GO:0000796) |
0.2 | 0.7 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 0.5 | GO:0032449 | CBM complex(GO:0032449) |
0.2 | 1.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 0.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 1.0 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.2 | 1.7 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 1.0 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 0.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.2 | 11.4 | GO:0055037 | recycling endosome(GO:0055037) |
0.2 | 2.4 | GO:1904949 | ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.2 | 2.8 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 0.7 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 3.5 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.2 | 1.4 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.2 | 5.0 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.2 | 0.7 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.2 | 1.6 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 27.0 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.2 | 9.5 | GO:1902493 | histone acetyltransferase complex(GO:0000123) protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.2 | 6.8 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 1.3 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.2 | 4.6 | GO:0015030 | Cajal body(GO:0015030) |
0.2 | 3.1 | GO:0005844 | polysome(GO:0005844) |
0.2 | 4.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.2 | 4.7 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.2 | 1.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 0.6 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 1.0 | GO:0016580 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.2 | 0.2 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.2 | 0.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 1.7 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.2 | 0.6 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 1.2 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 0.6 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.2 | 2.5 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.2 | 7.9 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.2 | 0.2 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 1.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 1.8 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.2 | 0.6 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.2 | 9.0 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 35.1 | GO:0000785 | chromatin(GO:0000785) |
0.2 | 2.1 | GO:0032156 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.2 | 1.9 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 1.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.2 | 0.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 14.5 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 0.2 | GO:0043197 | dendritic spine(GO:0043197) |
0.2 | 1.1 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 16.5 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.2 | 1.3 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.2 | 1.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 0.5 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.2 | 1.1 | GO:0030897 | HOPS complex(GO:0030897) |
0.2 | 8.3 | GO:0016605 | PML body(GO:0016605) |
0.2 | 0.4 | GO:0038201 | TORC1 complex(GO:0031931) TOR complex(GO:0038201) |
0.2 | 1.0 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.2 | 0.2 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 0.2 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.2 | 0.5 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.2 | 0.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 3.1 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.2 | 2.0 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 7.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 1.9 | GO:0042627 | chylomicron(GO:0042627) |
0.2 | 5.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.2 | 0.5 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.2 | 1.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 3.5 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.2 | 0.7 | GO:0042825 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.2 | 0.2 | GO:0031253 | cell projection membrane(GO:0031253) |
0.2 | 0.5 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.2 | 1.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.2 | 0.5 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.2 | 0.5 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.2 | 2.9 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.2 | 0.3 | GO:0000803 | sex chromosome(GO:0000803) |
0.2 | 0.6 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.2 | 1.9 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.2 | 0.2 | GO:0070820 | tertiary granule(GO:0070820) |
0.2 | 0.6 | GO:0000346 | transcription export complex(GO:0000346) |
0.2 | 1.4 | GO:0031672 | A band(GO:0031672) |
0.2 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 0.6 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 1.0 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.1 | 0.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.7 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.1 | 0.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 6.2 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 5.3 | GO:0000228 | nuclear chromosome(GO:0000228) |
0.1 | 0.4 | GO:1990316 | pre-autophagosomal structure(GO:0000407) ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.3 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.1 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 1.3 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.7 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 2.4 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.1 | 0.1 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 1.0 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.1 | 0.8 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 1.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.1 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 1.7 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 0.4 | GO:0031501 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.8 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 1.2 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.9 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.9 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 1.0 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.5 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 4.9 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 0.5 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 2.9 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.3 | GO:0030120 | vesicle coat(GO:0030120) |
0.1 | 8.4 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.1 | 3.7 | GO:0009295 | nucleoid(GO:0009295) |
0.1 | 0.2 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 2.3 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 4.6 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.1 | 1.5 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 0.8 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 64.6 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 3.1 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 1.5 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.6 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 0.5 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 5.5 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 73.1 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 27.5 | GO:0005768 | endosome(GO:0005768) |
0.1 | 1.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 0.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 2.2 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.1 | 0.7 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 0.6 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 289.9 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 1.1 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.1 | 1.0 | GO:0030288 | outer membrane-bounded periplasmic space(GO:0030288) periplasmic space(GO:0042597) |
0.1 | 7.9 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 0.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.8 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.1 | 2.2 | GO:0030286 | dynein complex(GO:0030286) |
0.1 | 0.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 6.0 | GO:0019867 | outer membrane(GO:0019867) |
0.1 | 0.1 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
0.1 | 13.5 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 0.3 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.1 | 1.0 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 40.2 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 12.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 0.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 1.4 | GO:0031256 | leading edge membrane(GO:0031256) |
0.1 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.5 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 0.1 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 9.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 1.6 | GO:0043679 | axon terminus(GO:0043679) |
0.1 | 0.2 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 8.5 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.1 | 4.5 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 0.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 2.0 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.2 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.6 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 0.1 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 3.6 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 27.2 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.1 | GO:0043230 | extracellular organelle(GO:0043230) extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.1 | 0.4 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 0.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 10.0 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 0.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 0.3 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 5.1 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.4 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.2 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 3.1 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.1 | 44.6 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 0.4 | GO:0098858 | actin-based cell projection(GO:0098858) |
0.1 | 0.2 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.1 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.1 | 1.2 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.4 | GO:0031252 | cell leading edge(GO:0031252) |
0.1 | 3.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 0.5 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.1 | GO:1902554 | serine/threonine protein kinase complex(GO:1902554) |
0.0 | 3.9 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.4 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.7 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 125.6 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.4 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 54.4 | GO:0005622 | intracellular(GO:0005622) |
0.0 | 0.0 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 0.1 | GO:0042611 | MHC protein complex(GO:0042611) |
0.0 | 0.1 | GO:0005792 | obsolete microsome(GO:0005792) |
0.0 | 0.2 | GO:1990777 | protein-lipid complex(GO:0032994) plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.0 | 0.2 | GO:0005624 | obsolete membrane fraction(GO:0005624) |
0.0 | 0.0 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.0 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.0 | 0.0 | GO:0042383 | sarcolemma(GO:0042383) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 5.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.7 | 5.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
1.7 | 5.0 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
1.2 | 18.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
1.1 | 4.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
1.0 | 3.0 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
1.0 | 9.7 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
1.0 | 1.9 | GO:0004527 | exonuclease activity(GO:0004527) |
1.0 | 2.9 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.9 | 2.8 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.9 | 2.7 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.9 | 4.4 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.8 | 2.4 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.8 | 7.2 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.8 | 5.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.7 | 11.2 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.7 | 3.4 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.7 | 2.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.7 | 8.8 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.7 | 2.0 | GO:0016362 | activin receptor activity, type II(GO:0016362) |
0.7 | 2.6 | GO:0015925 | galactosidase activity(GO:0015925) |
0.7 | 2.0 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.7 | 2.0 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.6 | 3.8 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.6 | 1.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.6 | 5.0 | GO:0030332 | cyclin binding(GO:0030332) |
0.6 | 3.6 | GO:0035004 | phosphatidylinositol 3-kinase activity(GO:0035004) |
0.6 | 3.6 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.6 | 2.4 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.6 | 9.3 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.6 | 1.7 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.6 | 4.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.6 | 1.7 | GO:0005113 | patched binding(GO:0005113) |
0.6 | 1.7 | GO:0033691 | sialic acid binding(GO:0033691) |
0.6 | 1.7 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.5 | 3.3 | GO:0050733 | RS domain binding(GO:0050733) |
0.5 | 2.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.5 | 1.1 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.5 | 1.6 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.5 | 4.8 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.5 | 12.4 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.5 | 2.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.5 | 2.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.5 | 4.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.5 | 0.5 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.5 | 2.0 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.5 | 1.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.5 | 1.5 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.5 | 0.5 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.5 | 1.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.5 | 1.4 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.5 | 3.8 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.5 | 1.9 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.5 | 1.4 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.5 | 1.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.5 | 8.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.5 | 4.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.5 | 1.8 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.5 | 2.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.5 | 22.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.4 | 1.3 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.4 | 15.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.4 | 3.1 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.4 | 2.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.4 | 3.5 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.4 | 1.3 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.4 | 2.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.4 | 0.4 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.4 | 2.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.4 | 0.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.4 | 0.4 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.4 | 3.7 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.4 | 1.2 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.4 | 4.1 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.4 | 4.1 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.4 | 1.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.4 | 1.6 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.4 | 2.4 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.4 | 13.8 | GO:0036459 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.4 | 1.6 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.4 | 0.8 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.4 | 0.4 | GO:0043398 | HLH domain binding(GO:0043398) |
0.4 | 0.4 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.4 | 1.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.4 | 9.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.4 | 1.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.4 | 2.3 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.4 | 4.9 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.4 | 1.9 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.4 | 1.5 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.4 | 2.6 | GO:0008494 | translation activator activity(GO:0008494) |
0.4 | 1.1 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.4 | 1.1 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.4 | 1.9 | GO:0060229 | lipase activator activity(GO:0060229) |
0.4 | 2.6 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.4 | 0.7 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.4 | 1.8 | GO:0031996 | thioesterase binding(GO:0031996) |
0.4 | 1.5 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.4 | 1.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.4 | 2.2 | GO:0051400 | BH domain binding(GO:0051400) |
0.4 | 5.5 | GO:0043621 | protein self-association(GO:0043621) |
0.4 | 4.0 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.4 | 4.3 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.4 | 5.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.4 | 0.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.4 | 1.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.4 | 1.8 | GO:0031013 | troponin I binding(GO:0031013) |
0.3 | 1.7 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.3 | 0.3 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.3 | 0.3 | GO:0035197 | siRNA binding(GO:0035197) |
0.3 | 1.0 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.3 | 0.7 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.3 | 3.1 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.3 | 1.4 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.3 | 1.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.3 | 3.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 9.3 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.3 | 1.4 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.3 | 1.4 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.3 | 1.0 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.3 | 2.0 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.3 | 0.7 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.3 | 2.6 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.3 | 1.0 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.3 | 1.0 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.3 | 1.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.3 | 1.3 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.3 | 1.9 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.3 | 0.6 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.3 | 1.6 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.3 | 2.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.3 | 0.3 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.3 | 1.6 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.3 | 3.8 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.3 | 0.9 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.3 | 1.6 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.3 | 1.6 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.3 | 1.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.3 | 0.6 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.3 | 2.5 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 4.3 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.3 | 1.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 4.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.3 | 4.9 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.3 | 1.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.3 | 2.7 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.3 | 0.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.3 | 1.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.3 | 1.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.3 | 1.5 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.3 | 15.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.3 | 0.6 | GO:0045502 | dynein binding(GO:0045502) |
0.3 | 0.9 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 2.1 | GO:0004568 | chitinase activity(GO:0004568) |
0.3 | 0.6 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.3 | 0.9 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.3 | 0.9 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.3 | 0.9 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.3 | 0.3 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.3 | 1.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.3 | 1.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.3 | 2.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.3 | 0.9 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.3 | 2.6 | GO:0030276 | clathrin binding(GO:0030276) |
0.3 | 1.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.3 | 1.1 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.3 | 1.7 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.3 | 2.8 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.3 | 1.1 | GO:0015421 | oligopeptide-transporting ATPase activity(GO:0015421) |
0.3 | 1.4 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.3 | 7.3 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.3 | 0.3 | GO:0032558 | purine deoxyribonucleotide binding(GO:0032554) adenyl deoxyribonucleotide binding(GO:0032558) |
0.3 | 1.9 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 2.4 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.3 | 1.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.3 | 0.3 | GO:0019958 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.3 | 0.8 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.3 | 0.8 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.3 | 1.0 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.3 | 1.8 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.3 | 0.8 | GO:0019863 | IgE binding(GO:0019863) |
0.3 | 4.1 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.3 | 2.3 | GO:0017069 | snRNA binding(GO:0017069) |
0.3 | 0.8 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.3 | 1.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.3 | 0.3 | GO:0003896 | DNA primase activity(GO:0003896) |
0.3 | 6.0 | GO:0003823 | antigen binding(GO:0003823) |
0.3 | 1.0 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.2 | 1.0 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 4.5 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 1.0 | GO:0030911 | TPR domain binding(GO:0030911) |
0.2 | 0.7 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.2 | 1.0 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.2 | 1.0 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 1.0 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 2.0 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.2 | 2.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 0.2 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.2 | 1.5 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.2 | 2.6 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.2 | 1.2 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.2 | 0.2 | GO:0031491 | nucleosome binding(GO:0031491) |
0.2 | 1.6 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.2 | 5.6 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.2 | 0.9 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.2 | 1.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 3.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 1.1 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.2 | 1.4 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.2 | 0.9 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.2 | 1.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 0.7 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.2 | 0.7 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 4.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 2.9 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.2 | 0.9 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.2 | 1.6 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 2.4 | GO:0043022 | ribosome binding(GO:0043022) |
0.2 | 10.6 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 0.2 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.2 | 9.9 | GO:0042393 | histone binding(GO:0042393) |
0.2 | 2.9 | GO:0010181 | FMN binding(GO:0010181) |
0.2 | 1.5 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.2 | 1.1 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.2 | 1.7 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.2 | 4.3 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 0.8 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 0.8 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.2 | 1.9 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.2 | 0.6 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.2 | 0.6 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.2 | 0.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 7.5 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.2 | 1.3 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.2 | 2.1 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.2 | 2.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 1.0 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.2 | 2.5 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.2 | 1.0 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 0.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.2 | 0.8 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.2 | 0.6 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 0.6 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.2 | 1.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.2 | 0.4 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.2 | 0.8 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.2 | 0.6 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.2 | 3.4 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.2 | 0.8 | GO:0000739 | obsolete DNA strand annealing activity(GO:0000739) |
0.2 | 2.2 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.2 | 0.8 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.2 | 4.1 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.2 | 2.1 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.2 | 0.4 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 1.2 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.2 | 0.4 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.2 | 1.9 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.2 | 0.6 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.2 | 0.2 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.2 | 4.0 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.2 | 0.8 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 0.9 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.2 | 0.6 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.2 | 2.4 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.2 | 0.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.2 | 0.7 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.2 | 3.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 2.0 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.2 | 2.2 | GO:0019894 | kinesin binding(GO:0019894) |
0.2 | 0.5 | GO:1990939 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.2 | 0.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 4.7 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.2 | 0.4 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.2 | 1.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 0.9 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 0.7 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.2 | 14.4 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.2 | 1.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.2 | 0.7 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 1.1 | GO:0070403 | NAD+ binding(GO:0070403) |
0.2 | 1.4 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.2 | 0.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 3.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.2 | 0.5 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 0.2 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
0.2 | 5.7 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.2 | 0.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.2 | 0.3 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.2 | 0.7 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.2 | 0.7 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.2 | 0.5 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.2 | 0.8 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 1.0 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.2 | 0.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 4.8 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.2 | 1.7 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.2 | 3.6 | GO:0019843 | rRNA binding(GO:0019843) |
0.2 | 1.5 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.2 | 0.3 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.2 | 1.3 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.2 | 1.5 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 0.3 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 4.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.2 | 4.8 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.2 | 1.6 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.2 | 0.2 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 0.5 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.2 | 0.3 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.2 | 0.6 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.2 | 94.1 | GO:0003723 | RNA binding(GO:0003723) |
0.2 | 0.2 | GO:0052866 | phosphatidylinositol phosphate phosphatase activity(GO:0052866) |
0.2 | 0.3 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.2 | 8.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 1.9 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.2 | 1.3 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.2 | 0.5 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.2 | 1.1 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.2 | 0.6 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 3.1 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.2 | 1.1 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.2 | 1.4 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.2 | 0.8 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.2 | 2.6 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.2 | 0.5 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.4 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.1 | 4.9 | GO:0019205 | nucleobase-containing compound kinase activity(GO:0019205) |
0.1 | 1.9 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.1 | 0.6 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.4 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.1 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.1 | 0.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 1.2 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.6 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.1 | 1.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 1.7 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 2.7 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.1 | 0.4 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.1 | 0.7 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 0.6 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 2.9 | GO:0019829 | cation-transporting ATPase activity(GO:0019829) |
0.1 | 0.7 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 1.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 1.9 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.4 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 2.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.8 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.4 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 1.1 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.4 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 0.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.5 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 5.5 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.1 | 2.1 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.4 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.1 | 0.4 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.1 | 0.3 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 0.7 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.1 | 0.4 | GO:0045182 | translation regulator activity(GO:0045182) |
0.1 | 0.7 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 0.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 1.4 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.1 | 2.1 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.4 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 2.0 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 1.7 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.1 | 0.9 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.4 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 0.4 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 1.4 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 0.5 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.4 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 0.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 2.8 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.6 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.4 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.7 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.1 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 2.1 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 1.1 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.4 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 1.7 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 0.5 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.4 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.4 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 3.3 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 1.5 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 1.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.6 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.1 | 2.9 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 1.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.3 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.3 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.1 | 5.1 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 19.0 | GO:0016563 | obsolete transcription activator activity(GO:0016563) |
0.1 | 0.2 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 0.3 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
0.1 | 2.5 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.1 | 8.5 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.2 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.1 | 0.7 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 0.3 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 1.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.2 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 1.2 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.1 | 0.5 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.1 | 0.1 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 3.9 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.1 | 0.2 | GO:0042806 | fucose binding(GO:0042806) |
0.1 | 0.1 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.1 | 178.0 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.1 | 0.2 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 1.0 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 29.4 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 0.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.1 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 0.7 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.1 | 0.8 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 0.3 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.1 | 0.4 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 0.3 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 1.1 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.1 | 0.1 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 0.8 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.1 | 0.8 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.6 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 25.2 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 0.4 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 0.1 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.1 | 1.1 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.1 | 0.4 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.5 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.1 | 2.1 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.1 | 2.7 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 0.5 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 1.0 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 6.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.4 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.1 | 0.3 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.1 | 2.2 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.1 | 0.3 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 0.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.3 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 2.7 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.8 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.3 | GO:0000036 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) |
0.1 | 0.4 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.1 | 1.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.7 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.1 | 0.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 1.9 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.1 | 1.0 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 3.0 | GO:0008134 | transcription factor binding(GO:0008134) |
0.1 | 0.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.2 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 0.5 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
0.1 | 0.2 | GO:0016595 | glutamate binding(GO:0016595) |
0.1 | 0.2 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.1 | 0.6 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.1 | 0.4 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.2 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.1 | 0.4 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 0.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.2 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 0.1 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 8.3 | GO:0016874 | ligase activity(GO:0016874) |
0.1 | 0.4 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.5 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 1.1 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 7.1 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.1 | 0.2 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.9 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 0.5 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.1 | 0.2 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.1 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.3 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 0.3 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.1 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.1 | 0.9 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.9 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 0.4 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.2 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.1 | GO:0004428 | obsolete inositol or phosphatidylinositol kinase activity(GO:0004428) |
0.1 | 1.0 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 2.4 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 1.0 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.1 | 0.7 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.1 | GO:0070061 | fructose binding(GO:0070061) |
0.1 | 0.8 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.1 | 0.6 | GO:0019001 | guanyl nucleotide binding(GO:0019001) guanyl ribonucleotide binding(GO:0032561) |
0.1 | 0.3 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.1 | 0.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 1.7 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.1 | 3.7 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 0.3 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.1 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.1 | 0.2 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 0.7 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.1 | 0.1 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 0.7 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 2.4 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.1 | 0.1 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.1 | 0.9 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 1.4 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.1 | 0.3 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.2 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.0 | 0.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.2 | GO:0080031 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.8 | GO:0032934 | sterol binding(GO:0032934) |
0.0 | 0.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.2 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.0 | 0.4 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.2 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.0 | GO:0004407 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) NAD-dependent protein deacetylase activity(GO:0034979) |
0.0 | 0.5 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.3 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.9 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.1 | GO:0005048 | signal sequence binding(GO:0005048) |
0.0 | 0.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.0 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.0 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.5 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 0.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.5 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.1 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.0 | 0.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 2.1 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.1 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.0 | 0.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.0 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 6.3 | GO:0060589 | nucleoside-triphosphatase regulator activity(GO:0060589) |
0.0 | 0.1 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.6 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.3 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.0 | 0.2 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.2 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.0 | 0.1 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.1 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.1 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.5 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.0 | 0.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.8 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.1 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 0.1 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 1.5 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.0 | 0.1 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.0 | 0.0 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 2.0 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.2 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.0 | 0.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.2 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 3.1 | GO:0008233 | peptidase activity(GO:0008233) |
0.0 | 0.0 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.0 | GO:0005035 | death receptor activity(GO:0005035) |
0.0 | 0.0 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) DNA polymerase activity(GO:0034061) |
0.0 | 0.1 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.0 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.0 | 0.1 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.0 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.4 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 7.8 | GO:0008270 | zinc ion binding(GO:0008270) |
0.0 | 0.0 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.0 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.4 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.1 | GO:0043176 | amine binding(GO:0043176) |
0.0 | 0.0 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.0 | 0.0 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.0 | 0.4 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.1 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.0 | 0.0 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.0 | GO:0017166 | vinculin binding(GO:0017166) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 57.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.9 | 11.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.9 | 13.7 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.8 | 19.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.7 | 15.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.6 | 3.9 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.6 | 25.9 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.6 | 9.0 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.5 | 8.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.5 | 4.7 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.5 | 6.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.5 | 3.8 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.5 | 0.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.5 | 15.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.5 | 0.9 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.4 | 11.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.4 | 7.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.4 | 0.9 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.4 | 10.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.4 | 4.7 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.4 | 11.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.4 | 15.4 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.4 | 2.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.4 | 0.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.4 | 3.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.3 | 7.3 | PID BCR 5PATHWAY | BCR signaling pathway |
0.3 | 2.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.3 | 0.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.3 | 4.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.3 | 4.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.3 | 6.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.3 | 10.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.3 | 4.8 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.3 | 2.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.3 | 1.4 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.3 | 3.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 4.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.3 | 1.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 0.5 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.3 | 0.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 4.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.3 | 2.0 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 7.9 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 1.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 8.6 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 3.3 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.2 | 3.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 0.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 8.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 0.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 2.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 1.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.2 | 2.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 8.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 2.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 2.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 2.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 2.1 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 3.9 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 4.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.2 | 2.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 0.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 2.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 1.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 3.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 0.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 0.5 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.2 | 0.8 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 4.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 1.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 0.9 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 0.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 2.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 2.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.9 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 2.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 1.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 6.7 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 0.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 1.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 5.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 1.8 | PID ATM PATHWAY | ATM pathway |
0.1 | 3.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.6 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 3.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 0.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 1.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 0.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 0.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 3.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 0.6 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.7 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 1.0 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 1.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 1.2 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 0.6 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 1.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.5 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.8 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 0.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 0.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 0.8 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 0.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 2.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 0.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.7 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 2.2 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 0.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 1.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 1.3 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 0.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 0.9 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 1.9 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 2.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.7 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 0.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 0.5 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 0.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.6 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.4 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 8.4 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
1.4 | 15.4 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
1.4 | 4.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
1.1 | 3.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
1.1 | 26.0 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.9 | 10.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.7 | 16.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.7 | 10.0 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.7 | 15.2 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.6 | 17.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.6 | 5.6 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.5 | 8.2 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.5 | 4.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.5 | 9.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.5 | 6.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.5 | 7.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.5 | 7.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.5 | 0.5 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.5 | 1.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.5 | 2.9 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.5 | 7.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.5 | 1.9 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.5 | 4.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.4 | 20.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.4 | 5.5 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.4 | 0.8 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.4 | 7.2 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.4 | 6.8 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.4 | 4.6 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.4 | 1.9 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.4 | 14.8 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.4 | 5.3 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.4 | 0.4 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.4 | 10.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.4 | 4.7 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.4 | 1.4 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.4 | 7.9 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.4 | 7.0 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.4 | 8.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.3 | 5.2 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.3 | 1.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.3 | 0.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.3 | 1.0 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.3 | 2.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.3 | 3.3 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.3 | 6.1 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.3 | 1.3 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.3 | 6.7 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.3 | 1.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.3 | 3.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.3 | 0.9 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.3 | 0.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.3 | 0.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.3 | 3.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.3 | 1.1 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.3 | 4.5 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.3 | 3.9 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.3 | 3.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.3 | 2.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.3 | 3.0 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.3 | 13.0 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.3 | 0.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.3 | 3.7 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.3 | 3.9 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.3 | 1.0 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.3 | 0.3 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.2 | 4.7 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.2 | 0.5 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.2 | 11.1 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.2 | 6.9 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.2 | 0.2 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.2 | 4.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.2 | 0.7 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.2 | 0.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.2 | 14.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 0.7 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.2 | 0.7 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.2 | 0.7 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 5.2 | REACTOME KINESINS | Genes involved in Kinesins |
0.2 | 1.7 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 3.6 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.2 | 6.4 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 2.8 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.2 | 13.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.2 | 3.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.2 | 6.1 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.2 | 12.3 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.2 | 1.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 5.3 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.2 | 1.6 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.2 | 9.3 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.2 | 0.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.2 | 0.2 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.2 | 2.1 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.2 | 3.7 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.2 | 2.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.2 | 1.5 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.2 | 2.7 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 0.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.2 | 2.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.2 | 10.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 2.2 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.2 | 3.8 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.2 | 3.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.2 | 0.7 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.2 | 0.7 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.2 | 20.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 2.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.2 | 2.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 11.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 3.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 2.1 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 1.0 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.2 | 2.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 2.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 4.3 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.2 | 2.1 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.2 | 6.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 2.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 2.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.2 | 0.3 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.2 | 4.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 7.7 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.2 | 3.2 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 1.9 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 1.4 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 4.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 1.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 0.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 0.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 2.4 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 1.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 0.3 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 4.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 2.1 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 0.5 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.1 | 0.9 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 0.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 2.4 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 0.8 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 4.1 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 1.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.1 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.1 | 1.5 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 1.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 1.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 1.2 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 1.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 2.0 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 1.0 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 1.6 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 1.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 0.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 1.2 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 0.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 0.7 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 1.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 2.0 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 3.5 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.1 | 4.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 1.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 25.1 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 1.7 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 0.2 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 1.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 0.5 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 1.4 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 0.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 1.2 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 1.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 1.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 3.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 1.1 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 0.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 1.0 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 0.5 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 0.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 0.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 1.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.1 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.1 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 0.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 0.4 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 1.1 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 0.6 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 0.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 0.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 2.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.4 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.5 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.5 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.1 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.0 | 0.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 2.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.7 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 1.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.5 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.0 | 0.6 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.6 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 1.6 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 1.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.3 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.0 | 0.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 2.0 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 1.6 | REACTOME GPCR LIGAND BINDING | Genes involved in GPCR ligand binding |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.2 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.0 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 0.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.2 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.1 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.0 | 0.1 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |